 |
Prescription and Over-the-Counter Drug Product List
23rd Edition
Cumulative Supplement Number 5: May 2004
NOTE: The format for the Monthly Additions/Deletions Drug
Product List has changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.5
CUMULATIVE SUPPLEMENT LEGEND.
TABLET; ORAL
DARVOCET A500
>D> + AAIPHARMA 500MG;100MG N76429 001 Sep 10, 2003 Ma CRLD
>A> 500MG;100MG N76429 001 Sep 10, 2003 Ma CRLD
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN
>A> VINTAGE PHARMS 325MG;100MG N76743 001 May 07, 2004 Ma NEWA
ACETAZOLAMIDE SODIUM
INJECTABLE; INJECTION
ACETAZOLAMIDE SODIUM
>D> AP ABBOTT EQ 500MG BASE/VIAL N40108 001 Oct 30, 1995 Ma CAHN
>A> AP HOSPIRA EQ 500MG BASE/VIAL N40108 001 Oct 30, 1995 Ma CAHN
ACETIC ACID, GLACIAL
SOLUTION; IRRIGATION, URETHRAL
ACETIC ACID 0.25% IN PLASTIC CONTAINER
>D> AT ABBOTT 250MG/100ML N17656 001 Ma CAHN
>A> AT HOSPIRA 250MG/100ML N17656 001 Ma CAHN
ACETYLCYSTEINE
SOLUTION; INHALATION, ORAL
ACETYLCYSTEINE
>D> AN ABBOTT 10% N73664 001 Aug 30, 1994 Ma CAHN
>D> AN 20% N74037 001 Aug 30, 1994 Ma CAHN
>A> AN HOSPIRA 10% N73664 001 Aug 30, 1994 Ma CAHN
>A> AN 20% N74037 001 Aug 30, 1994 Ma CAHN
ACYCLOVIR SODIUM
INJECTABLE; INJECTION
ACYCLOVIR SODIUM
>D> AP ABBOTT EQ 500MG BASE/VIAL N74758 001 Apr 22, 1997 Ma CAHN
>D> AP EQ 500MG BASE/VIAL N74663 001 Apr 22, 1997 Ma CAHN
>D> AP EQ 1GM BASE/VIAL N74758 002 Apr 22, 1997 Ma CAHN
>D> AP EQ 1GM BASE/VIAL N74663 002 Apr 22, 1997 Ma CAHN
>A> AP HOSPIRA EQ 500MG BASE/VIAL N74758 001 Apr 22, 1997 Ma CAHN
>A> AP EQ 500MG BASE/VIAL N74663 001 Apr 22, 1997 Ma CAHN
>A> AP EQ 1GM BASE/VIAL N74758 002 Apr 22, 1997 Ma CAHN
>A> AP EQ 1GM BASE/VIAL N74663 002 Apr 22, 1997 Ma CAHN
ALCOHOL; DEXTROSE
INJECTABLE; INJECTION
ALCOHOL 5% IN D5-W
>D> AP ABBOTT 5ML/100ML;5GM/100ML N83263 001 Ma CAHN
>A> AP HOSPIRA 5ML/100ML;5GM/100ML N83263 001 Ma CAHN
ALFENTANIL HYDROCHLORIDE
INJECTABLE; INJECTION
ALFENTANIL
>D> AP ABBOTT EQ 0.5MG BASE/ML N75221 001 Oct 28, 1999 Ma CAHN
>A> AP HOSPIRA EQ 0.5MG BASE/ML N75221 001 Oct 28, 1999 Ma CAHN
AMIKACIN SULFATE
INJECTABLE; INJECTION
AMIKACIN SULFATE
>D> AP ABBOTT EQ 50MG BASE/ML N63263 001 Nov 30, 1994 Ma CAHN
>D> EQ 62.5MG BASE/ML N63283 001 Oct 31, 1994 Ma CAHN
>D> @ EQ 250MG BASE/ML N64099 001 Jun 20, 1995 Ma CAHN
>D> AP EQ 250MG BASE/ML N64098 001 Jun 26, 1995 Ma CAHN
>D> AP EQ 250MG BASE/ML N63264 001 Nov 30, 1994 Ma CAHN
>A> AP HOSPIRA EQ 50MG BASE/ML N63263 001 Nov 30, 1994 Ma CAHN
>A> EQ 62.5MG BASE/ML N63283 001 Oct 31, 1994 Ma CAHN
>A> @ EQ 250MG BASE/ML N64099 001 Jun 20, 1995 Ma CAHN
>A> AP HOSPIRA EQ 250MG BASE/ML N64098 001 Jun 26, 1995 Ma CAHN
>A> AP EQ 250MG BASE/ML N63264 001 Nov 30, 1994 Ma CAHN
AMIKACIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
>D> ABBOTT EQ 500MG BASE/100ML N64146 001 Apr 02, 1997 Ma CAHN
>A> HOSPIRA EQ 500MG BASE/100ML N64146 001 Apr 02, 1997 Ma CAHN
AMINO ACIDS
INJECTABLE; INJECTION
AMINOSYN 10%
>D> ABBOTT 10% (10GM/100ML) N17673 003 Ma CAHN
>A> HOSPIRA 10% (10GM/100ML) N17673 003 Ma CAHN
AMINOSYN 10% (PH6)
>D> ABBOTT 10% (10GM/100ML) N17673 008 Nov 18, 1985 Ma CAHN
>A> HOSPIRA 10% (10GM/100ML) N17673 008 Nov 18, 1985 Ma CAHN
AMINOSYN 3.5%
>D> ABBOTT 3.5% (3.5GM/100ML) N17789 004 Ma CAHN
>A> HOSPIRA 3.5% (3.5GM/100ML) N17789 004 Ma CAHN
AMINOSYN 5%
>D> ABBOTT 5% (5GM/100ML) N17673 001 Ma CAHN
>A> HOSPIRA 5% (5GM/100ML) N17673 001 Ma CAHN
AMINOSYN 7%
>D> @ ABBOTT 7% (7GM/100ML) N17673 002 Ma CAHN
>A> @ HOSPIRA 7% (7GM/100ML) N17673 002 Ma CAHN
AMINOSYN 7% (PH6)
>D> ABBOTT 7% (7GM/100ML) N17673 006 Nov 18, 1985 Ma CAHN
>A> HOSPIRA 7% (7GM/100ML) N17673 006 Nov 18, 1985 Ma CAHN
AMINOSYN 8.5%
>D> @ ABBOTT 8.5% (8.5GM/100ML) N17673 004 Ma CAHN
>A> @ HOSPIRA 8.5% (8.5GM/100ML) N17673 004 Ma CAHN
AMINOSYN 8.5% (PH6)
>D> ABBOTT 8.5% (8.5GM/100ML) N17673 007 Nov 18, 1985 Ma CAHN
>A> HOSPIRA 8.5% (8.5GM/100ML) N17673 007 Nov 18, 1985 Ma CAHN
AMINOSYN II 10%
>D> ABBOTT 10% (10GM/100ML) N19438 005 Apr 03, 1986 Ma CAHN
>A> HOSPIRA 10% (10GM/100ML) N19438 005 Apr 03, 1986 Ma CAHN
AMINOSYN II 10% IN PLASTIC CONTAINER
>D> ABBOTT 10% (10GM/100ML) N20015 001 Dec 19, 1991 Ma CAHN
>A> HOSPIRA 10% (10GM/100ML) N20015 001 Dec 19, 1991 Ma CAHN
AMINOSYN II 15% IN PLASTIC CONTAINER
>D> ABBOTT 15% (15GM/100ML) N20041 001 Dec 19, 1991 Ma CAHN
>A> HOSPIRA 15% (15GM/100ML) N20041 001 Dec 19, 1991 Ma CAHN
AMINOSYN II 3.5%
>D> @ ABBOTT 3.5% (3.5GM/100ML) N19438 001 Apr 03, 1986 Ma CAHN
>A> @ HOSPIRA 3.5% (3.5GM/100ML) N19438 001 Apr 03, 1986 Ma CAHN
AMINOSYN II 5%
>D> @ ABBOTT 5% (5GM/100ML) N19438 002 Apr 03, 1986 Ma CAHN
>A> @ HOSPIRA 5% (5GM/100ML) N19438 002 Apr 03, 1986 Ma CAHN
AMINOSYN II 7%
>D> ABBOTT 7% (7GM/100ML) N19438 003 Apr 03, 1986 Ma CAHN
>A> HOSPIRA 7% (7GM/100ML) N19438 003 Apr 03, 1986 Ma CAHN
AMINOSYN II 8.5%
>D> ABBOTT 8.5% (8.5GM/100ML) N19438 004 Apr 03, 1986 Ma CAHN
>A> HOSPIRA 8.5% (8.5GM/100ML) N19438 004 Apr 03, 1986 Ma CAHN
AMINOSYN-HBC 7%
>D> ABBOTT 7% (7GM/100ML) N19374 001 Jul 12, 1985 Ma CAHN
>A> HOSPIRA 7% (7GM/100ML) N19374 001 Jul 12, 1985 Ma CAHN
AMINOSYN-HF 8%
>D> ABBOTT 8% (8GM/100ML) N20345 001 Apr 04, 1996 Ma CAHN
>A> HOSPIRA 8% (8GM/100ML) N20345 001 Apr 04, 1996 Ma CAHN
AMINOSYN-PF 10%
>D> ABBOTT 10% (10GM/100ML) N19492 002 Oct 17, 1986 Ma CAHN
>A> HOSPIRA 10% (10GM/100ML) N19492 002 Oct 17, 1986 Ma CAHN
AMINOSYN-PF 7%
>D> ABBOTT 7% (7GM/100ML) N19398 001 Sep 06, 1985 Ma CAHN
>A> HOSPIRA 7% (7GM/100ML) N19398 001 Sep 06, 1985 Ma CAHN
AMINOSYN-RF 5.2%
>D> ABBOTT 5.2% (5.2GM/100ML) N18429 001 Ma CAHN
>A> HOSPIRA 5.2% (5.2GM/100ML) N18429 001 Ma CAHN
AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE;
INJECTABLE; INJECTION
AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER
>D> ABBOTT 3.5%;36.8MG/100ML;25GM/100ML;51MG N19683 001 Nov 07, 1988 Ma CAHN
/100ML;22.4MG/100ML;261MG/100ML;20
>A> HOSPIRA 3.5%;36.8MG/100ML;25GM/100ML;51MG N19683 001 Nov 07, 1988 Ma CAHN
/100ML;22.4MG/100ML;261MG/100ML;20
AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER
>D> ABBOTT 4.25%;36.8MG/100ML;20GM/100ML;51M N19683 002 Nov 07, 1988 Ma CAHN
G/100ML;22.4MG/100ML;261MG/100ML;2
05MG/100ML
>A> HOSPIRA 4.25%;36.8MG/100ML;20GM/100ML;51M N19683 002 Nov 07, 1988 Ma CAHN
G/100ML;22.4MG/100ML;261MG/100ML;2
05MG/100ML
AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER
>D> ABBOTT 4.25%;36.8MG/100ML;25GM/100ML;51M N19683 003 Nov 07, 1988 Ma CAHN
G/100ML;22.4MG/100ML;261MG/100ML;2
05MG/100ML
>A> HOSPIRA 4.25%;36.8MG/100ML;25GM/100ML;51M N19683 003 Nov 07, 1988 Ma CAHN
G/100ML;22.4MG/100ML;261MG/100ML;2
05MG/100ML
AMINOSYN II 5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER
>D> @ ABBOTT 5%;36.8MG/100ML;25GM/100ML;51MG/1 N19683 004 Nov 07, 1988 Ma CAHN
00ML;22.4MG/100ML;261MG/100ML;205
>A> @ HOSPIRA 5%;36.8MG/100ML;25GM/100ML;51MG/1 N19683 004 Nov 07, 1988 Ma CAHN
00ML;22.4MG/100ML;261MG/100ML;205
AMINO ACIDS; DEXTROSE
INJECTABLE; INJECTION
AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINER
>D> ABBOTT 3.5%;25GM/100ML N19681 001 Nov 01, 1988 Ma CAHN
>A> HOSPIRA 3.5%;25GM/100ML N19681 001 Nov 01, 1988 Ma CAHN
AMINOSYN II 3.5% IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> ABBOTT 3.5%;5GM/100ML N19681 002 Nov 01, 1988 Ma CAHN
>A> HOSPIRA 3.5%;5GM/100ML N19681 002 Nov 01, 1988 Ma CAHN
AMINOSYN II 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER
>D> ABBOTT 4.25%;10GM/100ML N19681 004 Nov 01, 1988 Ma CAHN
>A> HOSPIRA 4.25%;10GM/100ML N19681 004 Nov 01, 1988 Ma CAHN
AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER
>D> ABBOTT 4.25%;20GM/100ML N19681 005 Nov 01, 1988 Ma CAHN
>A> HOSPIRA 4.25%;20GM/100ML N19681 005 Nov 01, 1988 Ma CAHN
AMINOSYN II 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER
>D> ABBOTT 4.25%;25GM/100ML N19681 003 Nov 01, 1988 Ma CAHN
>A> HOSPIRA 4.25%;25GM/100ML N19681 003 Nov 01, 1988 Ma CAHN
AMINOSYN II 5% IN DEXTROSE 25% IN PLASTIC CONTAINER
>D> ABBOTT 5%;25GM/100ML N19681 006 Nov 01, 1988 Ma CAHN
>A> HOSPIRA 5%;25GM/100ML N19681 006 Nov 01, 1988 Ma CAHN
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM ACETATE; POTASSIUM CHLORIDE;
INJECTABLE; INJECTION
AMINOSYN II 4.25% W/ ELECT AND ADJUSTED PHOSPHATE IN DEXTROSE 10% IN PLASTIC
>D> @ ABBOTT 4.25%;10GM/100ML;51MG/100ML;176.5 N19682 003 Nov 01, 1988 Ma CAHN
MG/100ML;22.4MG/100ML;104.5MG/100
ML;205MG/100ML
>A> @ HOSPIRA 4.25%;10GM/100ML;51MG/100ML;176.5 N19682 003 Nov 01, 1988 Ma CAHN
MG/100ML;22.4MG/100ML;104.5MG/100
ML;205MG/100ML
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE;
INJECTABLE; INJECTION
AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> ABBOTT 3.5%;5GM/100ML;30MG/100ML;97MG/10 N19682 001 Nov 01, 1988 Ma CAHN
0ML;120MG/100ML;49.3MG/100ML
>A> HOSPIRA 3.5%;5GM/100ML;30MG/100ML;97MG/10 N19682 001 Nov 01, 1988 Ma CAHN
0ML;120MG/100ML;49.3MG/100ML
AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER
>D> ABBOTT 4.25%;5GM/100ML;30MG/100ML;97MG/1 N19682 002 Nov 01, 1988 Ma CAHN
00ML;120MG/100ML;49.3MG/100ML
>A> HOSPIRA 4.25%;5GM/100ML;30MG/100ML;97MG/1 N19682 002 Nov 01, 1988 Ma CAHN
00ML;120MG/100ML;49.3MG/100ML
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; SODIUM
INJECTABLE; INJECTION
AMINOSYN 3.5% M
>D> ABBOTT 3.5%;21MG/100ML;40MG/100ML;128MG/ N17789 003 Ma CAHN
100ML;234MG/100ML
>A> HOSPIRA 3.5%;21MG/100ML;40MG/100ML;128MG/ N17789 003 Ma CAHN
100ML;234MG/100ML
AMINO ACIDS; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION
AMINOSYN 3.5% M
>D> @ ABBOTT 3.5%;21MG/100ML;128MG/100ML;234M N17789 005 Ma CAHN
G/100ML
>A> @ HOSPIRA 3.5%;21MG/100ML;128MG/100ML;234M N17789 005 Ma CAHN
G/100ML
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC;
INJECTABLE; INJECTION
AMINOSYN II 10% W/ ELECTROLYTES
>D> ABBOTT 10%;102MG/100ML;45MG/100ML;522MG N19437 004 Apr 03, 1986 Ma CAHN
/100ML;410MG/100ML
>A> HOSPIRA 10%;102MG/100ML;45MG/100ML;522MG N19437 004 Apr 03, 1986 Ma CAHN
/100ML;410MG/100ML
AMINOSYN II 7% W/ ELECTROLYTES
>D> @ ABBOTT 7%;102MG/100ML;45MG/100ML;522MG/ N19437 006 Apr 03, 1986 Ma CAHN
100ML;410MG/100ML
>A> @ HOSPIRA 7%;102MG/100ML;45MG/100ML;522MG/ N19437 006 Apr 03, 1986 Ma CAHN
100ML;410MG/100ML
AMINOSYN II 8.5% W/ ELECTROLYTES
>D> ABBOTT 8.5%;102MG/100ML;45MG/100ML;522M N19437 005 Apr 03, 1986 Ma CAHN
G/100ML;410MG/100ML
>A> HOSPIRA 8.5%;102MG/100ML;45MG/100ML;522M N19437 005 Apr 03, 1986 Ma CAHN
G/100ML;410MG/100ML
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM
INJECTABLE; INJECTION
AMINOSYN II 3.5% M
>D> @ ABBOTT 3.5%;30MG/100ML;97MG/100ML;120MG/ N19437 007 Apr 03, 1986 Ma CAHN
100ML;49MG/100ML
>A> @ HOSPIRA 3.5%;30MG/100ML;97MG/100ML;120MG/ N19437 007 Apr 03, 1986 Ma CAHN
100ML;49MG/100ML
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
INJECTABLE; INJECTION
AMINOSYN 7% W/ ELECTROLYTES
>D> ABBOTT 7%;102MG/100ML;522MG/100ML;410MG N17789 002 Ma CAHN
>A> HOSPIRA 7%;102MG/100ML;522MG/100ML;410MG N17789 002 Ma CAHN
AMINOSYN 8.5% W/ ELECTROLYTES
>D> ABBOTT 8.5%;102MG/100ML;522MG/100ML;410M N17673 005 Ma CAHN
G/100ML
>A> HOSPIRA 8.5%;102MG/100ML;522MG/100ML;410M N17673 005 Ma CAHN
G/100ML
AMINOCAPROIC ACID
INJECTABLE; INJECTION
AMINOCAPROIC ACID
>D> AP ABBOTT 250MG/ML N70888 001 Jun 16, 1988 Ma CAHN
>A> AP HOSPIRA 250MG/ML N70888 001 Jun 16, 1988 Ma CAHN
AMINOCAPROIC ACID IN PLASTIC CONTAINER
>D> AP ABBOTT 250MG/ML N70010 001 Mar 09, 1987 Ma CAHN
>A> AP HOSPIRA 250MG/ML N70010 001 Mar 09, 1987 Ma CAHN
AMINOPHYLLINE
INJECTABLE; INJECTION
AMINOPHYLLINE
>D> AP + ABBOTT 25MG/ML N87601 001 Jul 23, 1982 Ma CAHN
>D> AP 25MG/ML N87242 001 Oct 26, 1983 Ma CAHN
>A> AP + HOSPIRA 25MG/ML N87601 001 Jul 23, 1982 Ma CAHN
>A> AP 25MG/ML N87242 001 Oct 26, 1983 Ma CAHN
AMINOPHYLLINE IN SODIUM CHLORIDE 0.45%
>D> + ABBOTT 100MG/100ML N88147 002 May 03, 1983 Ma CAHN
>D> + 200MG/100ML N88147 003 May 03, 1983 Ma CAHN
>A> + HOSPIRA 100MG/100ML N88147 002 May 03, 1983 Ma CAHN
>A> + 200MG/100ML N88147 003 May 03, 1983 Ma CAHN
AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
>D> @ ABBOTT 100MG/100ML N18924 001 Dec 12, 1984 Ma CAHN
>D> @ 200MG/100ML N18924 002 Dec 12, 1984 Ma CAHN
>D> @ ABBOTT 400MG/100ML N18924 003 Dec 12, 1984 Ma CAHN
>D> @ 500MG/100ML N18924 004 Dec 12, 1984 Ma CAHN
>A> @ HOSPIRA 100MG/100ML N18924 001 Dec 12, 1984 Ma CAHN
>A> @ 200MG/100ML N18924 002 Dec 12, 1984 Ma CAHN
>A> @ 400MG/100ML N18924 003 Dec 12, 1984 Ma CAHN
>A> @ 500MG/100ML N18924 004 Dec 12, 1984 Ma CAHN
AMIODARONE HYDROCHLORIDE
INJECTABLE; INJECTION
AMIODARONE HCL
>D> AP ABBOTT 50MG/ML N75955 001 Oct 18, 2002 Ma CAHN
>A> AP HOSPIRA 50MG/ML N75955 001 Oct 18, 2002 Ma CAHN
AMMONIUM CHLORIDE
INJECTABLE; INJECTION
AMMONIUM CHLORIDE IN PLASTIC CONTAINER
>D> + ABBOTT 5MEQ/ML N88366 001 Jun 13, 1984 Ma CAHN
>A> + HOSPIRA 5MEQ/ML N88366 001 Jun 13, 1984 Ma CAHN
AMMONIUM LACTATE
LOTION; TOPICAL
AMMONIUM LACTATE
>A> AB TARO EQ 12% BASE N76216 001 May 28, 2004 Ma NEWA
AMOXICILLIN; CLAVULANATE POTASSIUM
FOR SUSPENSION; ORAL
AMOXICILLIN AND CLAVULANATE POTASSIUM
>A> AB TEVA 200MG/5ML;EQ 28.5MG BASE/5ML N65089 001 May 25, 2004 Ma NEWA
>A> AB 400MG/5ML;EQ 57MG BASE/5ML N65089 002 May 25, 2004 Ma NEWA
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID;
INJECTABLE; INJECTION
M.V.I.-12
>A> + MAYNE PHARMA 20MG/ML;0.006MG/ML;0.5UGM/ML;1.5M N08809 005 Apr 22, 2004 Ma NEWA
G/ML;20
IU/ML;0.6MG/ML;4MG/ML;0.4MG/ML;0.36
MG/ML;0.6MG/ML;330 UNITS/ML;1 IU/ML
ATRACURIUM BESYLATE
INJECTABLE; INJECTION
ATRACURIUM BESYLATE
>D> AP ABBOTT 10MG/ML N74632 001 Dec 23, 1996 Ma CAHN
>A> AP HOSPIRA 10MG/ML N74632 001 Dec 23, 1996 Ma CAHN
ATRACURIUM BESYLATE PRESERVATIVE FREE
>D> AP ABBOTT 10MG/ML N74639 001 Mar 25, 1997 Ma CAHN
>D> AP 10MG/ML N74633 001 Dec 23, 1996 Ma CAHN
>A> AP HOSPIRA 10MG/ML N74639 001 Mar 25, 1997 Ma CAHN
>A> AP 10MG/ML N74633 001 Dec 23, 1996 Ma CAHN
TRACRIUM
>D> AP + ABBOTT 10MG/ML N18831 002 Jun 20, 1985 Ma CAHN
>A> AP + HOSPIRA 10MG/ML N18831 002 Jun 20, 1985 Ma CAHN
TRACRIUM PRESERVATIVE FREE
>D> AP + ABBOTT 10MG/ML N18831 001 Nov 23, 1983 Ma CAHN
>A> AP + HOSPIRA 10MG/ML N18831 001 Nov 23, 1983 Ma CAHN
ATROPINE SULFATE
INJECTABLE; IM-IV-SC
ATROPINE SULFATE ANSYR PLASTIC SYRINGE
>D> ABBOTT 0.05MG/ML N21146 002 Jul 09, 2001 Ma CAHN
>D> + 0.1MG/ML N21146 001 Jul 09, 2001 Ma CAHN
>A> HOSPIRA 0.05MG/ML N21146 002 Jul 09, 2001 Ma CAHN
>A> + 0.1MG/ML N21146 001 Jul 09, 2001 Ma CAHN
ATROPINE SULFATE; DIFENOXIN HYDROCHLORIDE
TABLET; ORAL
MOTOFEN
>D> + AMARIN PHARMS 0.025MG;1MG N17744 002 Ma CAHN
>A> + VALEANT 0.025MG;1MG N17744 002 Ma CAHN
MOTOFEN HALF-STRENGTH
>D> @ AMARIN PHARMS 0.025MG;0.5MG N17744 001 Ma CAHN
>A> @ VALEANT 0.025MG;0.5MG N17744 001 Ma CAHN
>A> AZACITIDINE
>A> INJECTABLE; SUBCUTANEOUS
>A> VIDAZA
>A> + PHARMION 100MG/VIAL N50794 001 May 19, 2004 Ma NEWA
>D> AZATADINE MALEATE
>D> TABLET; ORAL
>D> OPTIMINE
>D> + SCHERING 1MG N17601 001 Ma DISC
>A> @ 1MG N17601 001 Ma DISC
>D> AZATADINE MALEATE; PSEUDOEPHEDRINE SULFATE
>D> TABLET, EXTENDED RELEASE; ORAL
>D> TRINALIN
>D> + SCHERING 1MG;120MG N18506 001 Mar 23, 1982 Ma DISC
>A> @ 1MG;120MG N18506 001 Mar 23, 1982 Ma DISC
AZATHIOPRINE SODIUM
INJECTABLE; INJECTION
AZATHIOPRINE SODIUM
>D> AP BEDFORD EQ 100MG BASE/VIAL N74419 001 Mar 31, 1995 Ma CRLD
>A> + EQ 100MG BASE/VIAL N74419 001 Mar 31, 1995 Ma CRLD
>D> IMURAN
>D> AP + PROMETHEUS LABS EQ 100MG BASE/VIAL N17391 001 Ma DISC
>A> @ EQ 100MG BASE/VIAL N17391 001 Ma DISC
>A> BISACODYL; POLYETHYLENE GLYCOL; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM
>A> FOR SOLUTION; TABLET, DELAYED RELEASE; ORAL
>A> HALFLYTELY
>A> + BRAINTREE 5MG;210GM;0.74GM;2.86GM;5.6GM N21551 001 May 10, 2004 Ma NEWA
BRETYLIUM TOSYLATE
INJECTABLE; INJECTION
BRETYLIUM TOSYLATE
>D> AP + ABBOTT 50MG/ML N19033 001 Apr 29, 1986 Ma CAHN
>A> AP + HOSPIRA 50MG/ML N19033 001 Apr 29, 1986 Ma CAHN
BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> AP + ABBOTT 200MG/100ML N19008 002 Apr 29, 1986 Ma CAHN
>D> AP + 400MG/100ML N19008 003 Apr 29, 1986 Ma CAHN
>D> @ 800MG/100ML N19008 001 Apr 29, 1986 Ma CAHN
>A> AP + HOSPIRA 200MG/100ML N19008 002 Apr 29, 1986 Ma CAHN
>A> AP + 400MG/100ML N19008 003 Apr 29, 1986 Ma CAHN
>A> @ 800MG/100ML N19008 001 Apr 29, 1986 Ma CAHN
BRETYLIUM TOSYLATE IN PLASTIC CONTAINER
>D> AP + ABBOTT 50MG/ML N19030 001 Apr 29, 1986 Ma CAHN
>A> AP + HOSPIRA 50MG/ML N19030 001 Apr 29, 1986 Ma CAHN
BUMETANIDE
INJECTABLE; INJECTION
BUMETANIDE
>D> AP ABBOTT 0.25MG/ML N74332 001 Oct 31, 1994 Ma CAHN
>D> AP 0.25MG/ML N74160 001 Oct 30, 1997 Ma CAHN
>A> AP HOSPIRA 0.25MG/ML N74332 001 Oct 31, 1994 Ma CAHN
>A> AP 0.25MG/ML N74160 001 Oct 30, 1997 Ma CAHN
BUPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION
BUPIVACAINE HCL
>D> AP ABBOTT 0.25% N70590 001 Feb 17, 1987 Ma CAHN
>D> AP 0.25% N70586 001 Mar 03, 1987 Ma CAHN
>D> AP 0.25% N70583 001 Feb 17, 1987 Ma CAHN
>D> AP 0.25% N18053 002 Ma CAHN
>D> AP 0.5% N70609 001 Mar 03, 1987 Ma CAHN
>D> AP 0.5% N70597 001 Mar 03, 1987 Ma CAHN
>D> AP 0.5% N70584 001 Feb 17, 1986 Ma CAHN
>D> AP 0.5% N18053 001 Ma CAHN
>D> AP 0.75% N70587 001 Mar 03, 1987 Ma CAHN
>D> AP 0.75% N70585 001 Mar 03, 1987 Ma CAHN
>D> AP 0.75% N18053 003 Ma CAHN
>A> AP HOSPIRA 0.25% N70590 001 Feb 17, 1987 Ma CAHN
>A> AP 0.25% N70586 001 Mar 03, 1987 Ma CAHN
>A> AP 0.25% N70583 001 Feb 17, 1987 Ma CAHN
>A> AP 0.25% N18053 002 Ma CAHN
>A> AP 0.5% N70609 001 Mar 03, 1987 Ma CAHN
>A> AP 0.5% N70597 001 Mar 03, 1987 Ma CAHN
>A> AP 0.5% N70584 001 Feb 17, 1986 Ma CAHN
>A> AP 0.5% N18053 001 Ma CAHN
>A> AP 0.75% N70587 001 Mar 03, 1987 Ma CAHN
>A> AP 0.75% N70585 001 Mar 03, 1987 Ma CAHN
>A> AP 0.75% N18053 003 Ma CAHN
BUPIVACAINE HCL KIT
>D> @ ABBOTT 0.075% N19978 001 Sep 03, 1992 Ma CAHN
>D> @ 0.114% N19978 002 Sep 03, 1992 Ma CAHN
>D> @ 0.23% N19978 003 Sep 03, 1992 Ma CAHN
>A> @ HOSPIRA 0.075% N19978 001 Sep 03, 1992 Ma CAHN
>A> @ 0.114% N19978 002 Sep 03, 1992 Ma CAHN
>A> @ 0.23% N19978 003 Sep 03, 1992 Ma CAHN
MARCAINE HCL
>D> AP + ABBOTT 0.25% N16964 001 Ma CAHN
>D> AP + 0.5% N16964 006 Ma CAHN
>A> AP + HOSPIRA 0.25% N16964 001 Ma CAHN
>A> AP + 0.5% N16964 006 Ma CAHN
MARCAINE HCL PRESERVATIVE FREE
>D> AP + ABBOTT 0.25% N16964 012 Ma CAHN
>D> AP + 0.5% N16964 005 Ma CAHN
>D> AP + 0.75% N16964 009 Ma CAHN
>A> AP + HOSPIRA 0.25% N16964 012 Ma CAHN
>A> AP + 0.5% N16964 005 Ma CAHN
>A> AP + 0.75% N16964 009 Ma CAHN
INJECTABLE; SPINAL
BUPIVACAINE
>D> AP ABBOTT 0.75% N71810 001 Dec 11, 1987 Ma CAHN
>A> AP HOSPIRA 0.75% N71810 001 Dec 11, 1987 Ma CAHN
MARCAINE
>D> AP + ABBOTT 0.75% N18692 001 May 04, 1984 Ma CAHN
>A> AP + HOSPIRA 0.75% N18692 001 May 04, 1984 Ma CAHN
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE
INJECTABLE; INJECTION
BUPIVACAINE HCL AND EPINEPHRINE
>D> ABBOTT 0.25%;0.005MG/ML N71167 001 Jun 16, 1988 Ma CAHN
>D> 0.25%;0.005MG/ML N71166 001 Jun 16, 1988 Ma CAHN
>D> + 0.25%;0.005MG/ML N71165 001 Jun 16, 1988 Ma CAHN
>D> 0.5%;0.005MG/ML N71170 001 Jun 16, 1988 Ma CAHN
>D> 0.5%;0.005MG/ML N71169 001 Jun 16, 1988 Ma CAHN
>D> + 0.5%;0.005MG/ML N71168 001 Jun 16, 1988 Ma CAHN
>D> + 0.75%;0.005MG/ML N71171 001 Jun 16, 1988 Ma CAHN
>A> HOSPIRA 0.25%;0.005MG/ML N71167 001 Jun 16, 1988 Ma CAHN
>A> 0.25%;0.005MG/ML N71166 001 Jun 16, 1988 Ma CAHN
>A> + 0.25%;0.005MG/ML N71165 001 Jun 16, 1988 Ma CAHN
>A> 0.5%;0.005MG/ML N71170 001 Jun 16, 1988 Ma CAHN
>A> 0.5%;0.005MG/ML N71169 001 Jun 16, 1988 Ma CAHN
>A> + 0.5%;0.005MG/ML N71168 001 Jun 16, 1988 Ma CAHN
>A> + 0.75%;0.005MG/ML N71171 001 Jun 16, 1988 Ma CAHN
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
INJECTABLE; INJECTION
MARCAINE HCL W/ EPINEPHRINE
>D> AP + ABBOTT 0.25%;0.0091MG/ML N16964 004 Ma CAHN
>D> AP + 0.5%;0.0091MG/ML N16964 008 Ma CAHN
>A> AP + HOSPIRA 0.25%;0.0091MG/ML N16964 004 Ma CAHN
>A> AP + 0.5%;0.0091MG/ML N16964 008 Ma CAHN
MARCAINE HCL W/ EPINEPHRINE PRESERVATIVE FREE
>D> AP + ABBOTT 0.25%;0.0091MG/ML N16964 013 Ma CAHN
>D> AP + 0.5%;0.0091MG/ML N16964 007 Ma CAHN
>D> AP + 0.75%;0.0091MG/ML N16964 010 Ma CAHN
>A> AP + HOSPIRA 0.25%;0.0091MG/ML N16964 013 Ma CAHN
>A> AP + 0.5%;0.0091MG/ML N16964 007 Ma CAHN
>A> AP + HOSPIRA 0.75%;0.0091MG/ML N16964 010 Ma CAHN
BUPRENORPHINE HYDROCHLORIDE
INJECTABLE; INJECTION
BUPRENORPHINE HCL
>D> AP ABBOTT EQ 0.3MG BASE/ML N74137 001 Jun 03, 1996 Ma CAHN
>A> AP HOSPIRA EQ 0.3MG BASE/ML N74137 001 Jun 03, 1996 Ma CAHN
BUPROPION HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
BUPROPION HCL
>D> AB EON 100MG N75932 001 Nov 25, 2003 Ma CFTG
>A> AB1 100MG N75932 001 Nov 25, 2003 Ma CFTG
>D> AB 150MG N75932 002 Mar 22, 2004 Ma CTEC
>A> AB1 150MG N75932 002 Mar 22, 2004 Ma CTEC
>D> AB IMPAX LABS 100MG N75913 001 Jan 28, 2004 Ma CTEC
>A> AB1 100MG N75913 001 Jan 28, 2004 Ma CTEC
>A> AB2 150MG N75914 001 May 27, 2004 Ma NEWA
>D> AB 150MG N75913 002 Mar 22, 2004 Ma CTEC
>A> AB1 150MG N75913 002 Mar 22, 2004 Ma CTEC
WELLBUTRIN SR
>D> AB GLAXOSMITHKLINE 100MG N20358 002 Oct 04, 1996 Ma CTEC
>A> AB 100MG N20358 002 Oct 04, 1996 Ma CTEC
>D> AB + 150MG N20358 003 Oct 04, 1996 Ma CTEC
>A> AB + 150MG N20358 003 Oct 04, 1996 Ma CTEC
ZYBAN
>D> + GLAXOSMITHKLINE 150MG N20711 003 May 14, 1997 Ma CFTG
>A> AB + 150MG N20711 003 May 14, 1997 Ma CFTG
BUTORPHANOL TARTRATE
INJECTABLE; INJECTION
BUTORPHANOL TARTRATE
>D> AP ABBOTT 1MG/ML N75559 001 Mar 20, 2000 Ma CAHN
>D> AP 2MG/ML N75559 002 Mar 20, 2000 Ma CAHN
>A> AP HOSPIRA 1MG/ML N75559 001 Mar 20, 2000 Ma CAHN
>A> AP 2MG/ML N75559 002 Mar 20, 2000 Ma CAHN
BUTORPHANOL TARTRATE PRESERVATIVE FREE
>D> AP ABBOTT 1MG/ML N74626 001 Jan 23, 1997 Ma CAHN
>D> AP 1MG/ML N74620 001 Jan 22, 1997 Ma CAHN
>D> AP 2MG/ML N74626 002 Jan 23, 1997 Ma CAHN
>D> AP 2MG/ML N74620 002 Jan 22, 1997 Ma CAHN
>A> AP HOSPIRA 1MG/ML N74626 001 Jan 23, 1997 Ma CAHN
>A> AP 1MG/ML N74620 001 Jan 22, 1997 Ma CAHN
>A> AP 2MG/ML N74626 002 Jan 23, 1997 Ma CAHN
>A> AP 2MG/ML N74620 002 Jan 22, 1997 Ma CAHN
CALCIUM CHLORIDE
INJECTABLE; INJECTION
CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER
>D> + ABBOTT 100MG/ML N21117 001 Jan 28, 2000 Ma CAHN
>A> + HOSPIRA 100MG/ML N21117 001 Jan 28, 2000 Ma CAHN
CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
INJECTABLE; INJECTION
DEXTROSE 5% AND RINGER'S IN PLASTIC CONTAINER
>D> AP ABBOTT 33MG/100ML;5GM/100ML;30MG/100ML;8 N18254 001 Ma CAHN
60MG/100ML
>A> AP HOSPIRA 33MG/100ML;5GM/100ML;30MG/100ML;8 N18254 001 Ma CAHN
60MG/100ML
CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
INJECTABLE; INJECTION
DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
>D> AP ABBOTT 20MG/100ML;5GM/100ML;30MG/100ML;6 N17608 001 Ma CAHN
00MG/100ML;310MG/100ML
>A> AP HOSPIRA 20MG/100ML;5GM/100ML;30MG/100ML;6 N17608 001 Ma CAHN
00MG/100ML;310MG/100ML
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC
>D> @ ABBOTT 20MG/100ML;5GM/100ML;104MG/100ML; N19685 005 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
>D> @ ABBOTT 20MG/100ML;5GM/100ML;179MG/100ML; N19685 006 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
>A> @ HOSPIRA 20MG/100ML;5GM/100ML;104MG/100ML; N19685 005 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
>A> @ 20MG/100ML;5GM/100ML;179MG/100ML; N19685 006 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC
>D> @ ABBOTT 20MG/100ML;5GM/100ML;254MG/100ML; N19685 007 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
>A> @ HOSPIRA 20MG/100ML;5GM/100ML;254MG/100ML; N19685 007 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC
>D> AP ABBOTT 20MG/100ML;5GM/100ML;179MG/100ML; N19685 002 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
>D> AP 20MG/100ML;5GM/100ML;328MG/100ML; N19685 008 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
>A> AP HOSPIRA 20MG/100ML;5GM/100ML;179MG/100ML; N19685 002 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
>A> AP 20MG/100ML;5GM/100ML;328MG/100ML; N19685 008 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC
>D> @ ABBOTT 20MG/100ML;5GM/100ML;254MG/100ML; N19685 003 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
>A> @ HOSPIRA 20MG/100ML;5GM/100ML;254MG/100ML; N19685 003 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC
>D> AP ABBOTT 20MG/100ML;5GM/100ML;328MG/100ML; N19685 004 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
>A> AP HOSPIRA 20MG/100ML;5GM/100ML;328MG/100ML; N19685 004 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
>D> @ ABBOTT 20MG/100ML;5GM/100ML;104MG/100ML; N19685 001 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
>A> @ HOSPIRA 20MG/100ML;5GM/100ML;104MG/100ML; N19685 001 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM
INJECTABLE; INJECTION
TPN ELECTROLYTES IN PLASTIC CONTAINER
>D> ABBOTT 16.5MG/ML;25.4MG/ML;74.6MG/ML;121M N18895 001 Jul 20, 1984 Ma CAHN
G/ML;16.1MG/ML
>A> HOSPIRA 16.5MG/ML;25.4MG/ML;74.6MG/ML;121M N18895 001 Jul 20, 1984 Ma CAHN
G/ML;16.1MG/ML
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
SOLUTION; PERFUSION, CARDIAC
PLEGISOL IN PLASTIC CONTAINER
>D> AT + ABBOTT 17.6MG/100ML;325.3MG/100ML;119.3MG N18608 001 Feb 26, 1982 Ma CAHN
/100ML;643MG/100ML
>A> AT + HOSPIRA 17.6MG/100ML;325.3MG/100ML;119.3MG N18608 001 Feb 26, 1982 Ma CAHN
/100ML;643MG/100ML
CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
INJECTABLE; INJECTION
RINGER'S IN PLASTIC CONTAINER
>D> AP ABBOTT 33MG/100ML;30MG/100ML;860MG/100M N18251 001 Ma CAHN
>A> AP HOSPIRA 33MG/100ML;30MG/100ML;860MG/100M N18251 001 Ma CAHN
SOLUTION; IRRIGATION
RINGER'S IN PLASTIC CONTAINER
>D> AT ABBOTT 33MG/100ML;30MG/100ML;860MG/100M N17635 001 Ma CAHN
>A> AT HOSPIRA 33MG/100ML;30MG/100ML;860MG/100M N17635 001 Ma CAHN
CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
INJECTABLE; INJECTION
LACTATED RINGER'S IN PLASTIC CONTAINER
>D> AP ABBOTT 20MG/100ML;30MG/100ML;600MG/100M N17641 001 Ma CAHN
L;310MG/100ML
>A> AP HOSPIRA 20MG/100ML;30MG/100ML;600MG/100M N17641 001 Ma CAHN
L;310MG/100ML
SOLUTION; IRRIGATION
LACTATED RINGER'S IN PLASTIC CONTAINER
>D> AT ABBOTT 20MG/100ML;30MG/100ML;600MG/100M N19416 001 Jan 17, 1986 Ma CAHN
L;310MG/100ML
>A> AT HOSPIRA 20MG/100ML;30MG/100ML;600MG/100M N19416 001 Jan 17, 1986 Ma CAHN
L;310MG/100ML
CAPTOPRIL
TABLET; ORAL
CAPTOPRIL
>A> AB DURAMED PHARMS 12.5MG N74477 001 Feb 13, 1996 Ma CAHN
>A> AB 25MG N74477 002 Feb 13, 1996 Ma CAHN
>A> AB 50MG N74477 003 Feb 13, 1996 Ma CAHN
>A> AB 100MG N74477 004 Feb 13, 1996 Ma CAHN
>D> AB HALLMARK PHARMS 12.5MG N74477 001 Feb 13, 1996 Ma CAHN
>D> AB 25MG N74477 002 Feb 13, 1996 Ma CAHN
>D> AB 50MG N74477 003 Feb 13, 1996 Ma CAHN
>D> AB 100MG N74477 004 Feb 13, 1996 Ma CAHN
CARBIDOPA; LEVODOPA
TABLET, EXTENDED RELEASE; ORAL
CARBIDOPA AND LEVODOPA
>A> AB IMPAX LABS 25MG;100MG N76521 001 May 14, 2004 Ma NEWA
>A> AB 50MG;200MG N76521 002 May 14, 2004 Ma NEWA
CEFACLOR
FOR SUSPENSION; ORAL
CECLOR
>A> AB CEPH INTL EQ 125MG BASE/5ML N62206 001 Ma CAHN
>A> AB EQ 187MG BASE/5ML N62206 003 Apr 20, 1988 Ma CAHN
>A> AB EQ 250MG BASE/5ML N62206 002 Ma CAHN
>A> AB + EQ 375MG BASE/5ML N62206 004 Apr 20, 1988 Ma CAHN
>D> AB LILLY EQ 125MG BASE/5ML N62206 001 Ma CAHN
>D> AB EQ 187MG BASE/5ML N62206 003 Apr 20, 1988 Ma CAHN
>D> AB EQ 250MG BASE/5ML N62206 002 Ma CAHN
>D> AB + EQ 375MG BASE/5ML N62206 004 Apr 20, 1988 Ma CAHN
CEFTAZIDIME
INJECTABLE; INJECTION
TAZICEF
>D> AP ABBOTT 500MG/VIAL N62662 001 Mar 06, 1986 Ma CAHN
>D> AP 1GM/VIAL N64032 001 Oct 31, 1993 Ma CAHN
>D> AP 1GM/VIAL N62662 002 Mar 06, 1986 Ma CAHN
>D> AP 2GM/VIAL N64032 002 Oct 31, 1993 Ma CAHN
>D> AP 2GM/VIAL N62662 003 Mar 06, 1986 Ma CAHN
>D> AP 6GM/VIAL N62662 004 Mar 06, 1986 Ma CAHN
>A> AP HOSPIRA 500MG/VIAL N62662 001 Mar 06, 1986 Ma CAHN
>A> AP 1GM/VIAL N64032 001 Oct 31, 1993 Ma CAHN
>A> AP 1GM/VIAL N62662 002 Mar 06, 1986 Ma CAHN
>A> AP 2GM/VIAL N64032 002 Oct 31, 1993 Ma CAHN
>A> AP 2GM/VIAL N62662 003 Mar 06, 1986 Ma CAHN
>A> AP 6GM/VIAL N62662 004 Mar 06, 1986 Ma CAHN
CHLOROPROCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
CHLOROPROCAINE HCL
>D> AP ABBOTT 2% N87447 001 Apr 16, 1982 Ma CAHN
>D> AP 3% N87446 001 Apr 16, 1982 Ma CAHN
>A> AP HOSPIRA 2% N87447 001 Apr 16, 1982 Ma CAHN
>A> AP 3% N87446 001 Apr 16, 1982 Ma CAHN
CHORIOGONADOTROPIN ALFA
>D> INJECTABLE; INJECTION
>D> OVIDREL
>D> + SERONO INC 0.25MG/VIAL N21149 001 Sep 20, 2000 Ma DISC
>A> @ 0.25MG/VIAL N21149 001 Sep 20, 2000 Ma DISC
CHROMIC CHLORIDE
INJECTABLE; INJECTION
CHROMIC CHLORIDE IN PLASTIC CONTAINER
>D> + ABBOTT EQ 0.004MG CHROMIUM/ML N18961 001 Jun 26, 1986 Ma CAHN
>A> + HOSPIRA EQ 0.004MG CHROMIUM/ML N18961 001 Jun 26, 1986 Ma CAHN
CIMETIDINE HYDROCHLORIDE
INJECTABLE; INJECTION
CIMETIDINE HCL
>D> AP ABBOTT EQ 300MG BASE/2ML N74422 001 Jan 31, 1995 Ma CAHN
>D> AP EQ 300MG BASE/2ML N74412 001 Mar 28, 1997 Ma CAHN
>D> AP EQ 300MG BASE/2ML N74345 001 Jan 31, 1995 Ma CAHN
>D> AP EQ 300MG BASE/2ML N74344 001 Jan 31, 1995 Ma CAHN
>D> AP EQ 300MG BASE/2ML N74296 001 Mar 28, 1997 Ma CAHN
>A> AP HOSPIRA EQ 300MG BASE/2ML N74422 001 Jan 31, 1995 Ma CAHN
>A> AP EQ 300MG BASE/2ML N74412 001 Mar 28, 1997 Ma CAHN
>A> AP EQ 300MG BASE/2ML N74345 001 Jan 31, 1995 Ma CAHN
>A> AP EQ 300MG BASE/2ML N74344 001 Jan 31, 1995 Ma CAHN
>A> AP EQ 300MG BASE/2ML N74296 001 Mar 28, 1997 Ma CAHN
CIMETIDINE HCL IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
>D> AP ABBOTT EQ 6MG BASE/ML N74269 001 Dec 27, 1994 Ma CAHN
>D> + EQ 90MG BASE/100ML N74468 005 Dec 29, 1994 Ma CAHN
>D> + EQ 120MG BASE/100ML N74468 006 Dec 29, 1994 Ma CAHN
>D> + EQ 180MG BASE/100ML N74468 003 Dec 29, 1994 Ma CAHN
>D> + EQ 240MG BASE/100ML N74468 004 Dec 29, 1994 Ma CAHN
>D> + EQ 360MG BASE/100ML N74468 001 Dec 29, 1994 Ma CAHN
>D> + EQ 480MG BASE/100ML N74468 002 Dec 29, 1994 Ma CAHN
>A> AP HOSPIRA EQ 6MG BASE/ML N74269 001 Dec 27, 1994 Ma CAHN
>A> + EQ 90MG BASE/100ML N74468 005 Dec 29, 1994 Ma CAHN
>A> + EQ 120MG BASE/100ML N74468 006 Dec 29, 1994 Ma CAHN
>A> + EQ 180MG BASE/100ML N74468 003 Dec 29, 1994 Ma CAHN
>A> + EQ 240MG BASE/100ML N74468 004 Dec 29, 1994 Ma CAHN
>A> + EQ 360MG BASE/100ML N74468 001 Dec 29, 1994 Ma CAHN
>A> + EQ 480MG BASE/100ML N74468 002 Dec 29, 1994 Ma CAHN
CITRIC ACID; MAGNESIUM OXIDE; SODIUM CARBONATE
SOLUTION; IRRIGATION
UROLOGIC G IN PLASTIC CONTAINER
>D> AT ABBOTT 3.24GM/100ML;380MG/100ML;430MG/10 N18904 001 May 27, 1983 Ma CAHN
>A> AT HOSPIRA 3.24GM/100ML;380MG/100ML;430MG/10 N18904 001 May 27, 1983 Ma CAHN
CLARITHROMYCIN
TABLET; ORAL
BIAXIN
>D> + ABBOTT 250MG N50662 001 Oct 31, 1991 Ma CFTG
>A> AB + 250MG N50662 001 Oct 31, 1991 Ma CFTG
>D> + 500MG N50662 002 Oct 31, 1991 Ma CFTG
>A> AB + 500MG N50662 002 Oct 31, 1991 Ma CFTG
>A> CLARITHROMYCIN
>A> AB ROXANE 250MG N65178 002 May 25, 2004 Ma NEWA
>A> AB 500MG N65178 001 May 25, 2004 Ma NEWA
CLINDAMYCIN PALMITATE HYDROCHLORIDE
FOR SOLUTION; ORAL
CLEOCIN
>D> PHARMACIA AND EQ 75MG BASE/5ML N62644 001 Apr 07, 1986 Ma CRLD
>A> + EQ 75MG BASE/5ML N62644 001 Apr 07, 1986 Ma CRLD
CLINDAMYCIN PHOSPHATE
INJECTABLE; INJECTION
CLINDAMYCIN PHOSPHATE
>D> @ ABBOTT EQ 150MG BASE/ML N62943 001 Sep 29, 1988 Ma CAHN
>D> AP EQ 150MG BASE/ML N62801 001 Jul 24, 1987 Ma CAHN
>D> AP EQ 150MG BASE/ML N62800 001 Jul 24, 1987 Ma CAHN
>A> @ HOSPIRA EQ 150MG BASE/ML N62943 001 Sep 29, 1988 Ma CAHN
>A> AP EQ 150MG BASE/ML N62801 001 Jul 24, 1987 Ma CAHN
>A> AP EQ 150MG BASE/ML N62800 001 Jul 24, 1987 Ma CAHN
CUPRIC CHLORIDE
INJECTABLE; INJECTION
CUPRIC CHLORIDE IN PLASTIC CONTAINER
>D> + ABBOTT EQ 0.4MG COPPER/ML N18960 001 Jun 26, 1986 Ma CAHN
>A> + HOSPIRA EQ 0.4MG COPPER/ML N18960 001 Jun 26, 1986 Ma CAHN
DEFEROXAMINE MESYLATE
INJECTABLE; INJECTION
DEFEROXAMINE MESYLATE
>D> AP ABBOTT 500MG/VIAL N76019 001 Mar 17, 2004 Ma CAHN
>D> AP 2GM/VIAL N76019 002 Mar 17, 2004 Ma CAHN
>A> AP HOSPIRA 500MG/VIAL N76019 001 Mar 17, 2004 Ma CAHN
>A> AP 2GM/VIAL N76019 002 Mar 17, 2004 Ma CAHN
DESMOPRESSIN ACETATE
INJECTABLE; INJECTION
DESMOPRESSIN ACETATE
>D> AP ABBOTT 0.004MG/ML N75220 001 Aug 28, 2000 Ma CAHN
>A> AP HOSPIRA 0.004MG/ML N75220 001 Aug 28, 2000 Ma CAHN
DEXMEDETOMIDINE
INJECTABLE; INJECTION
PRECEDEX
>D> + ABBOTT EQ 100UGM BASE/ML N21038 001 Dec 17, 1999 Ma CAHN
>A> + HOSPIRA EQ 100UGM BASE/ML N21038 001 Dec 17, 1999 Ma CAHN
DEXTROSE
INJECTABLE; INJECTION
DEXTROSE 10% IN PLASTIC CONTAINER
>D> AP ABBOTT 10GM/100ML N18080 001 Ma CAHN
>A> AP HOSPIRA 10GM/100ML N18080 001 Ma CAHN
DEXTROSE 2.5% IN PLASTIC CONTAINER
>D> B BRAUN 2.5GM/100ML N18358 001 Ma DISC
>A> @ 2.5GM/100ML N18358 001 Ma DISC
DEXTROSE 20% IN PLASTIC CONTAINER
>D> AP ABBOTT 20GM/100ML N18564 001 Mar 23, 1982 Ma CAHN
>A> AP HOSPIRA 20GM/100ML N18564 001 Mar 23, 1982 Ma CAHN
DEXTROSE 25%
>D> ABBOTT 250MG/ML N19445 002 Nov 23, 1998 Ma CAHN
>A> HOSPIRA 250MG/ML N19445 002 Nov 23, 1998 Ma CAHN
DEXTROSE 30% IN PLASTIC CONTAINER
>D> AP ABBOTT 30GM/100ML N19345 001 Jan 26, 1985 Ma CAHN
>A> AP HOSPIRA 30GM/100ML N19345 001 Jan 26, 1985 Ma CAHN
DEXTROSE 40% IN PLASTIC CONTAINER
>D> AP ABBOTT 40GM/100ML N18562 001 Mar 23, 1982 Ma CAHN
>A> AP HOSPIRA 40GM/100ML N18562 001 Mar 23, 1982 Ma CAHN
DEXTROSE 5% IN PLASTIC CONTAINER
>D> AP ABBOTT 50MG/ML N19222 001 Jul 13, 1984 Ma CAHN
>D> AP 50MG/ML N16367 002 Ma CAHN
>D> AP 5GM/100ML N19479 001 Sep 17, 1985 Ma CAHN
>D> AP 5GM/100ML N19466 001 Jul 15, 1985 Ma CAHN
>A> AP HOSPIRA 50MG/ML N19222 001 Jul 13, 1984 Ma CAHN
>A> AP 50MG/ML N16367 002 Ma CAHN
>A> AP 5GM/100ML N19479 001 Sep 17, 1985 Ma CAHN
>A> AP 5GM/100ML N19466 001 Jul 15, 1985 Ma CAHN
DEXTROSE 50% IN PLASTIC CONTAINER
>D> @ ABBOTT 500MG/ML N19445 001 Jun 03, 1986 Ma CAHN
>D> AP 50GM/100ML N19894 001 Dec 26, 1989 Ma CAHN
>D> AP 50GM/100ML N18563 001 Mar 23, 1982 Ma CAHN
>A> @ HOSPIRA 500MG/ML N19445 001 Jun 03, 1986 Ma CAHN
>A> AP 50GM/100ML N19894 001 Dec 26, 1989 Ma CAHN
>A> AP 50GM/100ML N18563 001 Mar 23, 1982 Ma CAHN
DEXTROSE 60% IN PLASTIC CONTAINER
>D> AP ABBOTT 60GM/100ML N19346 001 Jan 25, 1985 Ma CAHN
>A> AP HOSPIRA 60GM/100ML N19346 001 Jan 25, 1985 Ma CAHN
DEXTROSE 70% IN PLASTIC CONTAINER
>D> AP ABBOTT 70GM/100ML N19893 001 Dec 26, 1989 Ma CAHN
>D> AP 70GM/100ML N18561 001 Mar 23, 1982 Ma CAHN
>A> AP HOSPIRA 70GM/100ML N19893 001 Dec 26, 1989 Ma CAHN
>A> AP 70GM/100ML N18561 001 Mar 23, 1982 Ma CAHN
DEXTROSE; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION
NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER
>D> ABBOTT 5GM/100ML;21MG/100ML;128MG/100ML; N17610 001 Ma CAHN
234MG/100ML
>A> HOSPIRA 5GM/100ML;21MG/100ML;128MG/100ML; N17610 001 Ma CAHN
234MG/100ML
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC;
INJECTABLE; INJECTION
>D> ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER
>D> B BRAUN 5GM/100ML;31MG/100ML;130MG/100ML; N19025 001 Dec 27, 1984 Ma DISC
26MG/100ML;320MG/100ML
>A> @ 5GM/100ML;31MG/100ML;130MG/100ML; N19025 001 Dec 27, 1984 Ma DISC
26MG/100ML;320MG/100ML
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC;
INJECTABLE; INJECTION
IONOSOL B AND DEXTROSE 5% IN PLASTIC CONTAINER
>D> ABBOTT 5GM/100ML;53MG/100ML;100MG/100ML; N19515 001 May 08, 1986 Ma CAHN
100MG/100ML;180MG/100ML;280MG/100
ML;16MG/100ML
>A> HOSPIRA 5GM/100ML;53MG/100ML;100MG/100ML; N19515 001 May 08, 1986 Ma CAHN
100MG/100ML;180MG/100ML;280MG/100
ML;16MG/100ML
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC;
INJECTABLE; INJECTION
IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER
>D> ABBOTT 5GM/100ML;30MG/100ML;141MG/100ML; N19513 001 May 08, 1986 Ma CAHN
15MG/100ML;260MG/100ML;25MG/100M
>A> HOSPIRA 5GM/100ML;30MG/100ML;141MG/100ML; N19513 001 May 08, 1986 Ma CAHN
15MG/100ML;260MG/100ML;25MG/100M
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION
ISOLYTE H W/ DEXTROSE 5% IN PLASTIC CONTAINER
>D> B BRAUN 5GM/100ML;30MG/100ML;97MG/100ML;2 N18273 001 Ma DISC
20MG/100ML;140MG/100ML
>A> @ 5GM/100ML;30MG/100ML;97MG/100ML;2 N18273 001 Ma DISC
20MG/100ML;140MG/100ML
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE;
INJECTABLE; INJECTION
NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER
>D> ABBOTT 5GM/100ML;30MG/100ML;37MG/100ML;2 N17609 001 Ma CAHN
22MG/100ML;526MG/100ML;502MG/100
>A> HOSPIRA 5GM/100ML;30MG/100ML;37MG/100ML;2 N17609 001 Ma CAHN
22MG/100ML;526MG/100ML;502MG/100
DEXTROSE; POTASSIUM CHLORIDE
INJECTABLE; INJECTION
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> ABBOTT 5GM/100ML;149MG/100ML N18371 001 Ma CAHN
>A> HOSPIRA 5GM/100ML;149MG/100ML N18371 001 Ma CAHN
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> AP ABBOTT 5GM/100ML;224MG/100ML N18371 003 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;224MG/100ML N18371 003 Ma CAHN
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> ABBOTT 5GM/100ML;298MG/100ML N18371 002 Ma CAHN
>A> HOSPIRA 5GM/100ML;298MG/100ML N18371 002 Ma CAHN
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM LACTATE; SODIUM CHLORIDE; SODIUM
INJECTABLE; INJECTION
IONOSOL T AND DEXTROSE 5% IN PLASTIC CONTAINER
>D> ABBOTT 5GM/100ML;111MG/100ML;256MG/100M N19514 001 May 08, 1986 Ma CAHN
L;146MG/100ML;207MG/100ML
>A> HOSPIRA 5GM/100ML;111MG/100ML;256MG/100M N19514 001 May 08, 1986 Ma CAHN
L;146MG/100ML;207MG/100ML
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM
INJECTABLE; INJECTION
ISOLYTE M W/ DEXTROSE 5% IN PLASTIC CONTAINER
>D> B BRAUN 5GM/100ML;150MG/100ML;130MG/100M N18270 001 Ma DISC
L;280MG/100ML;91MG/100ML
>A> @ 5GM/100ML;150MG/100ML;130MG/100M N18270 001 Ma DISC
L;280MG/100ML;91MG/100ML
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
INJECTABLE; INJECTION
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC
>D> ABBOTT 5GM/100ML;74.5MG/100ML;225MG/100ML N18365 002 Jul 05, 1983 Ma CAHN
>D> 5GM/100ML;149MG/100ML;225MG/100M N18365 006 Mar 28, 1988 Ma CAHN
>A> HOSPIRA 5GM/100ML;74.5MG/100ML;225MG/100ML N18365 002 Jul 05, 1983 Ma CAHN
>A> 5GM/100ML;149MG/100ML;225MG/100M N18365 006 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC
>D> ABBOTT 5GM/100ML;74.5MG/100ML;300MG/100ML N18876 001 Jan 17, 1986 Ma CAHN
>D> 5GM/100ML;149MG/100ML;300MG/100M N18876 006 Mar 28, 1988 Ma CAHN
>A> HOSPIRA 5GM/100ML;74.5MG/100ML;300MG/100ML N18876 001 Jan 17, 1986 Ma CAHN
>A> 5GM/100ML;149MG/100ML;300MG/100M N18876 006 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC
>D> AP ABBOTT 5GM/100ML;74.5MG/100ML;450MG/100ML N18362 005 Mar 28, 1988 Ma CAHN
>D> AP 5GM/100ML;74.5MG/100ML;450MG/100ML N18362 009 Jul 05, 1983 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;74.5MG/100ML;450MG/100ML N18362 005 Mar 28, 1988 Ma CAHN
>A> AP 5GM/100ML;74.5MG/100ML;450MG/100ML N18362 009 Jul 05, 1983 Ma CAHN
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC
>D> AP ABBOTT 5GM/100ML;74.5MG/100ML;900MG/100ML N19691 002 Mar 24, 1988 Ma CAHN
>D> AP 5GM/100ML;149MG/100ML;900MG/100M N19691 004 Mar 24, 1988 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;74.5MG/100ML;900MG/100ML N19691 002 Mar 24, 1988 Ma CAHN
>A> AP 5GM/100ML;149MG/100ML;900MG/100M N19691 004 Mar 24, 1988 Ma CAHN
POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC
>D> ABBOTT 5GM/100ML;224MG/100ML;225MG/100M N18365 008 Mar 28, 1988 Ma CAHN
>A> HOSPIRA 5GM/100ML;224MG/100ML;225MG/100M N18365 008 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC
>D> ABBOTT 5GM/100ML;224MG/100ML;300MG/100M N18876 007 Mar 28, 1988 Ma CAHN
>A> HOSPIRA 5GM/100ML;224MG/100ML;300MG/100M N18876 007 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC
>D> AP ABBOTT 5GM/100ML;224MG/100ML;450MG/100M N18362 006 Mar 28, 1988 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;224MG/100ML;450MG/100M N18362 006 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC
>D> AP ABBOTT 5GM/100ML;224MG/100ML;900MG/100M N19691 006 Mar 24, 1988 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;224MG/100ML;900MG/100M N19691 006 Mar 24, 1988 Ma CAHN
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC
>D> ABBOTT 5GM/100ML;149MG/100ML;225MG/100M N18365 001 Ma CAHN
>D> 5GM/100ML;298MG/100ML;225MG/100M N18365 009 Mar 28, 1988 Ma CAHN
>A> HOSPIRA 5GM/100ML;149MG/100ML;225MG/100M N18365 001 Ma CAHN
>A> 5GM/100ML;298MG/100ML;225MG/100M N18365 009 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC
>D> ABBOTT 5GM/100ML;298MG/100ML;300MG/100M N18876 008 Mar 28, 1988 Ma CAHN
>A> HOSPIRA 5GM/100ML;298MG/100ML;300MG/100M N18876 008 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC
>D> AP ABBOTT 5GM/100ML;149MG/100ML;450MG/100M N18362 010 Jul 05, 1983 Ma CAHN
>D> AP 5GM/100ML;298MG/100ML;450MG/100M N18362 007 Mar 28, 1988 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;149MG/100ML;450MG/100M N18362 010 Jul 05, 1983 Ma CAHN
>A> AP 5GM/100ML;298MG/100ML;450MG/100M N18362 007 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC
>D> AP ABBOTT 5GM/100ML;149MG/100ML;900MG/100M N19691 005 Mar 24, 1988 Ma CAHN
>D> AP 5GM/100ML;298MG/100ML;900MG/100M N19691 008 Mar 24, 1988 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;149MG/100ML;900MG/100M N19691 005 Mar 24, 1988 Ma CAHN
>A> AP 5GM/100ML;298MG/100ML;900MG/100M N19691 008 Mar 24, 1988 Ma CAHN
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN SODIUM CHLORIDE 0.3% IN PLASTIC
>D> ABBOTT 5GM/100ML;149MG/100ML;300MG/100M N18876 002 Jan 17, 1986 Ma CAHN
>A> HOSPIRA 5GM/100ML;149MG/100ML;300MG/100M N18876 002 Jan 17, 1986 Ma CAHN
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC
>D> ABBOTT 5GM/100ML;224MG/100ML;225MG/100M N18365 003 Jul 05, 1983 Ma CAHN
>A> HOSPIRA 5GM/100ML;224MG/100ML;225MG/100M N18365 003 Jul 05, 1983 Ma CAHN
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC
>D> ABBOTT 5GM/100ML;224MG/100ML;300MG/100M N18876 003 Jan 17, 1986 Ma CAHN
>A> HOSPIRA 5GM/100ML;224MG/100ML;300MG/100M N18876 003 Jan 17, 1986 Ma CAHN
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC
>D> AP ABBOTT 5GM/100ML;224MG/100ML;450MG/100M N18362 002 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;224MG/100ML;450MG/100M N18362 002 Ma CAHN
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC
>D> AP ABBOTT 5GM/100ML;224MG/100ML;900MG/100M N19691 007 Mar 24, 1988 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;224MG/100ML;900MG/100M N19691 007 Mar 24, 1988 Ma CAHN
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC
>D> ABBOTT 5GM/100ML;298MG/100ML;225MG/100M N18365 004 Jul 05, 1983 Ma CAHN
>A> HOSPIRA 5GM/100ML;298MG/100ML;225MG/100M N18365 004 Jul 05, 1983 Ma CAHN
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC
>D> ABBOTT 5GM/100ML;298MG/100ML;300MG/100M N18876 004 Mar 28, 1988 Ma CAHN
>A> HOSPIRA 5GM/100ML;298MG/100ML;300MG/100M N18876 004 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC
CONTAINER
>D> AP ABBOTT 5GM/100ML;298MG/100ML;450MG/100M N18362 003 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;298MG/100ML;450MG/100M N18362 003 Ma CAHN
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC
>D> AP ABBOTT 5GM/100ML;298MG/100ML;900MG/100M N19691 009 Mar 24, 1988 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;298MG/100ML;900MG/100M N19691 009 Mar 24, 1988 Ma CAHN
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC
>D> ABBOTT 5GM/100ML;74.5MG/100ML;225MG/100ML N18365 005 Mar 28, 1988 Ma CAHN
>D> 5GM/100ML;149MG/100ML;225MG/100M N18365 007 Mar 28, 1988 Ma CAHN
>A> HOSPIRA 5GM/100ML;74.5MG/100ML;225MG/100ML N18365 005 Mar 28, 1988 Ma CAHN
>A> 5GM/100ML;149MG/100ML;225MG/100M N18365 007 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC
>D> ABBOTT 5GM/100ML;74.5MG/100ML;300MG/100ML N18876 005 Mar 28, 1988 Ma CAHN
>D> 5GM/100ML;149MG/100ML;300MG/100M N18876 009 Mar 28, 1988 Ma CAHN
>A> HOSPIRA 5GM/100ML;74.5MG/100ML;300MG/100ML N18876 005 Mar 28, 1988 Ma CAHN
>A> 5GM/100ML;149MG/100ML;300MG/100M N18876 009 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC
>D> AP ABBOTT 5GM/100ML;74.5MG/100ML;450MG/100ML N18362 008 Mar 28, 1988 Ma CAHN
>D> AP 5GM/100ML;149MG/100ML;450MG/100M N18362 004 Mar 28, 1988 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;74.5MG/100ML;450MG/100ML N18362 008 Mar 28, 1988 Ma CAHN
>A> AP 5GM/100ML;149MG/100ML;450MG/100M N18362 004 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC
>D> AP ABBOTT 5GM/100ML;74.5MG/100ML;900MG/100ML N19691 001 Mar 24, 1988 Ma CAHN
>D> AP 5GM/100ML;149MG/100ML;900MG/100M N19691 003 Mar 24, 1988 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;74.5MG/100ML;900MG/100ML N19691 001 Mar 24, 1988 Ma CAHN
>A> AP 5GM/100ML;149MG/100ML;900MG/100M N19691 003 Mar 24, 1988 Ma CAHN
DEXTROSE; SODIUM CHLORIDE
INJECTABLE; INJECTION
DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
>D> AP ABBOTT 2.5GM/100ML;450MG/100ML N18096 001 Ma CAHN
>A> AP HOSPIRA 2.5GM/100ML;450MG/100ML N18096 001 Ma CAHN
DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
>D> ABBOTT 5GM/100ML;225MG/100ML N17606 001 Ma CAHN
>A> HOSPIRA 5GM/100ML;225MG/100ML N17606 001 Ma CAHN
DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
>D> ABBOTT 5GM/100ML;300MG/100ML N17799 001 Ma CAHN
>A> HOSPIRA 5GM/100ML;300MG/100ML N17799 001 Ma CAHN
DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
>D> AP ABBOTT 5GM/100ML;450MG/100ML N17607 001 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;450MG/100ML N17607 001 Ma CAHN
DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
>D> AP ABBOTT 5GM/100ML;900MG/100ML N17585 001 Ma CAHN
>A> AP 5GM/100ML;900MG/100ML N17585 001 Ma CAHN
DIATRIZOATE MEGLUMINE
INJECTABLE; INJECTION
HYPAQUE
>D> AP + AMERSHAM HLTH 30% N16403 002 Ma DISC
>A> @ GE HEALTHCARE 30% N16403 002 Ma DISC
RENO-DIP
>D> AP + BRACCO 30% N10040 012 Ma CRLD
>A> + 30% N10040 012 Ma CRLD
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
INJECTABLE; INJECTION
>D> HYPAQUE-76
>D> AP AMERSHAM HLTH 66%;10% N86505 001 Ma DISC
>A> @ GE HEALTHCARE 66%;10% N86505 001 Ma DISC
DIAZEPAM
INJECTABLE; INJECTION
DIAZEPAM
>D> AP ABBOTT 5MG/ML N72079 001 Dec 20, 1988 Ma CAHN
>D> AP 5MG/ML N71584 001 Oct 13, 1987 Ma CAHN
>D> AP + 5MG/ML N71583 001 Oct 13, 1987 Ma CAHN
>A> AP HOSPIRA 5MG/ML N72079 001 Dec 20, 1988 Ma CAHN
>A> AP 5MG/ML N71584 001 Oct 13, 1987 Ma CAHN
>A> AP + 5MG/ML N71583 001 Oct 13, 1987 Ma CAHN
DIGOXIN
INJECTABLE; INJECTION
DIGOXIN
>D> AP ABBOTT 0.25MG/ML N40206 001 Aug 28, 1998 Ma CAHN
>D> AP 0.25MG/ML N40093 001 May 16, 1996 Ma CAHN
>A> AP HOSPIRA 0.25MG/ML N40206 001 Aug 28, 1998 Ma CAHN
>A> AP 0.25MG/ML N40093 001 May 16, 1996 Ma CAHN
DIGOXIN PEDIATRIC
>D> AP ABBOTT 0.1MG/ML N40092 001 Apr 25, 1996 Ma CAHN
>A> AP HOSPIRA 0.1MG/ML N40092 001 Apr 25, 1996 Ma CAHN
DILTIAZEM HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL
DILT-CD
>A> AB3 TORPHARM 120MG N76151 001 May 20, 2004 Ma NEWA
>A> AB3 180MG N76151 002 May 20, 2004 Ma NEWA
>A> AB3 240MG N76151 003 May 20, 2004 Ma NEWA
>A> AB3 300MG N76151 004 May 20, 2004 Ma NEWA
INJECTABLE; INJECTION
DILTIAZEM HCL
>D> AP ABBOTT 5MG/ML N75004 001 Feb 16, 2000 Ma CAHN
>D> AP 5MG/ML N74941 001 Apr 15, 1998 Ma CAHN
>D> AP 100MG/VIAL N75853 001 Dec 17, 2002 Ma CAHN
>A> AP HOSPIRA 5MG/ML N75004 001 Feb 16, 2000 Ma CAHN
>A> AP 5MG/ML N74941 001 Apr 15, 1998 Ma CAHN
>A> AP 100MG/VIAL N75853 001 Dec 17, 2002 Ma CAHN
DIPHENHYDRAMINE HYDROCHLORIDE
INJECTABLE; INJECTION
DIPHENHYDRAMINE HCL
>D> AP ABBOTT 50MG/ML N40140 001 Nov 20, 1998 Ma CAHN
>A> AP HOSPIRA 50MG/ML N40140 001 Nov 20, 1998 Ma CAHN
DIPYRIDAMOLE
INJECTABLE; INJECTION
DIPYRIDAMOLE
>D> AP ABBOTT 5MG/ML N74601 001 Dec 19, 1997 Ma CAHN
>A> AP HOSPIRA 5MG/ML N74601 001 Dec 19, 1997 Ma CAHN
DOBUTAMINE HYDROCHLORIDE
INJECTABLE; INJECTION
DOBUTAMINE HCL
>D> AP ABBOTT EQ 12.5MG BASE/ML N74292 001 Feb 16, 1995 Ma CAHN
>D> AP EQ 12.5MG BASE/ML N74086 001 Nov 29, 1993 Ma CAHN
>D> AP EQ 1.25GM BASE/100ML N74634 001 Sep 27, 1996 Ma CAHN
>A> AP HOSPIRA EQ 12.5MG BASE/ML N74292 001 Feb 16, 1995 Ma CAHN
>A> AP EQ 12.5MG BASE/ML N74086 001 Nov 29, 1993 Ma CAHN
>A> AP EQ 1.25GM BASE/100ML N74634 001 Sep 27, 1996 Ma CAHN
DOBUTAMINE HCL IN DEXTROSE 5%
>D> AP + ABBOTT EQ 50MG BASE/100ML N20269 001 Oct 19, 1993 Ma CAHN
>D> AP + EQ 100MG BASE/100ML N20269 002 Oct 19, 1993 Ma CAHN
>D> AP + EQ 200MG BASE/100ML N20269 003 Oct 19, 1993 Ma CAHN
>A> AP + HOSPIRA EQ 50MG BASE/100ML N20269 001 Oct 19, 1993 Ma CAHN
>A> AP + EQ 100MG BASE/100ML N20269 002 Oct 19, 1993 Ma CAHN
>A> AP + EQ 200MG BASE/100ML N20269 003 Oct 19, 1993 Ma CAHN
DOBUTAMINE HCL IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> AP + ABBOTT EQ 50MG BASE/100ML N20201 003 Oct 19, 1993 Ma CAHN
>D> AP + EQ 100MG BASE/100ML N20201 002 Oct 19, 1993 Ma CAHN
>D> AP + EQ 200MG BASE/100ML N20201 001 Oct 19, 1993 Ma CAHN
>D> AP + EQ 400MG BASE/100ML N20201 006 Jul 07, 1994 Ma CAHN
>A> AP + HOSPIRA EQ 50MG BASE/100ML N20201 003 Oct 19, 1993 Ma CAHN
>A> AP + EQ 100MG BASE/100ML N20201 002 Oct 19, 1993 Ma CAHN
>A> AP + EQ 200MG BASE/100ML N20201 001 Oct 19, 1993 Ma CAHN
>A> AP + EQ 400MG BASE/100ML N20201 006 Jul 07, 1994 Ma CAHN
DOPAMINE HYDROCHLORIDE
INJECTABLE; INJECTION
DOPAMINE HCL
>D> AP ABBOTT 40MG/ML N74403 001 May 23, 1996 Ma CAHN
>D> AP + 40MG/ML N18132 001 Ma CAHN
>D> AP + ABBOTT 80MG/100ML N18132 002 Feb 04, 1982 Ma CAHN
>D> AP + 80MG/ML N18132 004 Jul 09, 1982 Ma CAHN
>D> AP + 160MG/100ML N18132 003 Feb 04, 1982 Ma CAHN
>A> AP HOSPIRA 40MG/ML N74403 001 May 23, 1996 Ma CAHN
>A> AP + 40MG/ML N18132 001 Ma CAHN
>A> AP + 80MG/100ML N18132 002 Feb 04, 1982 Ma CAHN
>A> AP + 80MG/ML N18132 004 Jul 09, 1982 Ma CAHN
>A> AP + 160MG/100ML N18132 003 Feb 04, 1982 Ma CAHN
DOPAMINE HCL IN DEXTROSE 5%
>D> AP + ABBOTT 1.6MG/ML N20542 001 Aug 30, 1995 Ma CAHN
>A> AP + HOSPIRA 1.6MG/ML N20542 001 Aug 30, 1995 Ma CAHN
DOPAMINE HCL IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> AP + ABBOTT 80MG/100ML N18826 001 Sep 30, 1983 Ma CAHN
>D> AP + 160MG/100ML N18826 002 Sep 30, 1983 Ma CAHN
>D> AP + 320MG/100ML N18826 003 Sep 30, 1983 Ma CAHN
>A> AP + HOSPIRA 80MG/100ML N18826 001 Sep 30, 1983 Ma CAHN
>A> AP + 160MG/100ML N18826 002 Sep 30, 1983 Ma CAHN
>A> AP + 320MG/100ML N18826 003 Sep 30, 1983 Ma CAHN
DROPERIDOL
INJECTABLE; INJECTION
DROPERIDOL
>D> AP ABBOTT 2.5MG/ML N72272 001 Aug 31, 1995 Ma CAHN
>D> AP 2.5MG/ML N71981 001 Feb 29, 1988 Ma CAHN
>A> AP HOSPIRA 2.5MG/ML N72272 001 Aug 31, 1995 Ma CAHN
>A> AP 2.5MG/ML N71981 001 Feb 29, 1988 Ma CAHN
DROPERIDOL; FENTANYL CITRATE
INJECTABLE; INJECTION
FENTANYL CITRATE AND DROPERIDOL
>D> + ABBOTT 2.5MG/ML;EQ 0.05MG BASE/ML N71982 001 May 04, 1988 Ma CAHN
>A> + HOSPIRA 2.5MG/ML;EQ 0.05MG BASE/ML N71982 001 May 04, 1988 Ma CAHN
EDETATE DISODIUM
INJECTABLE; INJECTION
ENDRATE
>D> AP + ABBOTT 150MG/ML N11355 001 Ma CAHN
>A> AP + HOSPIRA 150MG/ML N11355 001 Ma CAHN
EDROPHONIUM CHLORIDE
INJECTABLE; INJECTION
EDROPHONIUM CHLORIDE
>D> AP ABBOTT 10MG/ML N40131 001 Feb 24, 1998 Ma CAHN
>A> AP HOSPIRA 10MG/ML N40131 001 Feb 24, 1998 Ma CAHN
ENALAPRILAT
INJECTABLE; INJECTION
ENALAPRILAT
>D> AP ABBOTT 1.25MG/ML N75458 001 Aug 22, 2000 Ma CAHN
>D> AP 1.25MG/ML N75456 001 Aug 22, 2000 Ma CAHN
>A> AP HOSPIRA 1.25MG/ML N75458 001 Aug 22, 2000 Ma CAHN
>A> AP 1.25MG/ML N75456 001 Aug 22, 2000 Ma CAHN
EPINEPHRINE
INJECTABLE; INTRAMUSCULAR, SUBCUTANEOUS
>A> EPINEPHRINE
>A> + HOLLISTER STIER EQ 0.15MG /DELIVERY N20800 002 May 28, 2004 Ma NEWA
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
LIDOCAINE HCL AND EPINEPHRINE
>D> AP ABBOTT 0.005MG/ML;0.5% N89635 001 Jun 21, 1988 Ma CAHN
>D> AP 0.005MG/ML;1% N89649 001 Jun 21, 1988 Ma CAHN
>D> AP 0.005MG/ML;1.5% N89650 001 Jun 21, 1988 Ma CAHN
>D> AP 0.005MG/ML;1.5% N89645 001 Jun 21, 1988 Ma CAHN
>D> AP 0.005MG/ML;1.5% N88571 001 Sep 13, 1985 Ma CAHN
>D> AP 0.005MG/ML;2% N89651 001 Jun 21, 1988 Ma CAHN
>D> AP 0.01MG/ML;1% N89644 001 Jun 21, 1988 Ma CAHN
>D> AP 0.01MG/ML;2% N89646 001 Jun 21, 1988 Ma CAHN
>A> AP HOSPIRA 0.005MG/ML;0.5% N89635 001 Jun 21, 1988 Ma CAHN
>A> AP HOSPIRA 0.005MG/ML;1% N89649 001 Jun 21, 1988 Ma CAHN
>A> AP 0.005MG/ML;1.5% N89650 001 Jun 21, 1988 Ma CAHN
>A> AP 0.005MG/ML;1.5% N89645 001 Jun 21, 1988 Ma CAHN
>A> AP 0.005MG/ML;1.5% N88571 001 Sep 13, 1985 Ma CAHN
>A> AP 0.005MG/ML;2% N89651 001 Jun 21, 1988 Ma CAHN
>A> AP 0.01MG/ML;1% N89644 001 Jun 21, 1988 Ma CAHN
>A> AP 0.01MG/ML;2% N89646 001 Jun 21, 1988 Ma CAHN
>A> PATCH; IONTOPHORESIS
>A> LIDOSITE TOPICAL SYSTEM KIT
>A> + VYTERIS 1.05MG/PATCH;100MG/PATCH N21504 001 May 06, 2004 Ma NEWA
ERYTHROMYCIN LACTOBIONATE
INJECTABLE; INJECTION
ERYTHROCIN
>D> AP ABBOTT EQ 500MG BASE/VIAL N62638 001 Oct 31, 1986 Ma CAHN
>D> AP EQ 500MG BASE/VIAL N50609 001 Sep 24, 1986 Ma CAHN
>D> AP + EQ 500MG BASE/VIAL N50182 002 Ma CAHN
>D> AP EQ 1GM BASE/VIAL N62638 002 Oct 31, 1986 Ma CAHN
>D> AP EQ 1GM BASE/VIAL N50609 002 Sep 24, 1986 Ma CAHN
>D> AP + EQ 1GM BASE/VIAL N50182 003 Ma CAHN
>A> AP HOSPIRA EQ 500MG BASE/VIAL N62638 001 Oct 31, 1986 Ma CAHN
>A> AP EQ 500MG BASE/VIAL N50609 001 Sep 24, 1986 Ma CAHN
>A> AP + EQ 500MG BASE/VIAL N50182 002 Ma CAHN
>A> AP EQ 1GM BASE/VIAL N62638 002 Oct 31, 1986 Ma CAHN
>A> AP EQ 1GM BASE/VIAL N50609 002 Sep 24, 1986 Ma CAHN
>A> AP + EQ 1GM BASE/VIAL N50182 003 Ma CAHN
ESTRADIOL ACETATE
INSERT, EXTENDED RELEASE; VAGINAL
FEMRING
>D> GALEN LTD 0.05MG/24HR N21367 001 Mar 20, 2003 Ma CPOT
>A> EQ 0.05MG BASE/24HR N21367 001 Mar 20, 2003 Ma CPOT
>D> + 0.1MG/24HR N21367 002 Mar 20, 2003 Ma CPOT
>A> + EQ 0.1MG BASE/24HR N21367 002 Mar 20, 2003 Ma CPOT
ESTROGENS, CONJUGATED
TABLET; ORAL
PREMARIN
>D> WYETH PHARMS INC 2.5MG N04782 002 Ma DISC
>A> @ 2.5MG N04782 002 Ma DISC
>A> ESTROGENS, CONJUGATED SYNTHETIC B
>A> TABLET; ORAL
>A> ENJUVIA
>A> DURAMED 0.625MG N21443 003 May 10, 2004 Ma NEWA
>A> + 1.25MG N21443 004 May 10, 2004 Ma NEWA
ETHAMBUTOL HYDROCHLORIDE
TABLET; ORAL
MYAMBUTOL
>D> @ ELAN PHARMS 100MG N16320 001 Ma CMFD
>D> @ 200MG N16320 002 Ma CAHN
>D> @ 400MG N16320 003 Ma CMFD
>D> @ 500MG N16320 004 Ma CAHN
>A> AB STAT TRADE 100MG N16320 001 Ma CMFD
>A> @ 200MG N16320 002 Ma CAHN
>A> AB 400MG N16320 003 Ma CMFD
>A> @ 500MG N16320 004 Ma CAHN
ETHINYL ESTRADIOL; LEVONORGESTREL
TABLET; ORAL-21
LEVLITE
>D> AB + BERLEX 0.02MG;0.1MG N20860 001 Jul 13, 1998 Ma CTEC
>A> AB2 + 0.02MG;0.1MG N20860 001 Jul 13, 1998 Ma CTEC
TABLET; ORAL-28
LESSINA-28
>D> AB BARR 0.02MG;0.1MG N75803 002 Mar 20, 2002 Ma CTEC
>A> AB2 0.02MG;0.1MG N75803 002 Mar 20, 2002 Ma CTEC
LEVLITE
>D> AB BERLEX 0.02MG;0.1MG N20860 002 Jul 13, 1998 Ma CTEC
>A> AB2 BERLEX 0.02MG;0.1MG N20860 002 Jul 13, 1998 Ma CTEC
ETODOLAC
TABLET, EXTENDED RELEASE; ORAL
LODINE XL
>D> AB + WYETH PHARMS INC 400MG N20584 001 Oct 25, 1996 Ma CRLD
>A> AB 400MG N20584 001 Oct 25, 1996 Ma CRLD
>D> AB + 500MG N20584 003 Jan 20, 1998 Ma CRLD
>A> AB 500MG N20584 003 Jan 20, 1998 Ma CRLD
ETOMIDATE
INJECTABLE; INJECTION
AMIDATE
>D> AP + ABBOTT 2MG/ML N18227 001 Sep 07, 1982 Ma CAHN
>A> AP + HOSPIRA 2MG/ML N18227 001 Sep 07, 1982 Ma CAHN
ETOPOSIDE
INJECTABLE; INJECTION
ETOPOSIDE
>D> AP ABBOTT 20MG/ML N74351 001 Aug 30, 1995 Ma CAHN
>D> AP 20MG/ML N74320 001 Aug 30, 1995 Ma CAHN
>A> AP HOSPIRA 20MG/ML N74351 001 Aug 30, 1995 Ma CAHN
>A> AP 20MG/ML N74320 001 Aug 30, 1995 Ma CAHN
FAMOTIDINE
INJECTABLE; INJECTION
FAMOTIDINE
>D> AP ABBOTT 10MG/ML N75905 001 Nov 23, 2001 Ma CAHN
>D> AP 10MG/ML N75870 001 Nov 23, 2001 Ma CAHN
>A> AP HOSPIRA 10MG/ML N75905 001 Nov 23, 2001 Ma CAHN
>A> AP 10MG/ML N75870 001 Nov 23, 2001 Ma CAHN
FENOLDOPAM MESYLATE
INJECTABLE; INJECTION
CORLOPAM
>D> AP + ABBOTT EQ 10MG BASE/ML N19922 001 Sep 23, 1997 Ma CAHN
>A> AP + HOSPIRA EQ 10MG BASE/ML N19922 001 Sep 23, 1997 Ma CAHN
FENTANYL CITRATE
INJECTABLE; INJECTION
FENTANYL CITRATE
>D> AP ABBOTT EQ 0.05MG BASE/ML N19115 001 Jan 12, 1985 Ma CAHN
>A> AP HOSPIRA EQ 0.05MG BASE/ML N19115 001 Jan 12, 1985 Ma CAHN
FENTANYL CITRATE PRESERVATIVE FREE
>D> AP ABBOTT EQ 0.05MG BASE/ML N72786 001 Sep 24, 1991 Ma CAHN
>A> AP HOSPIRA EQ 0.05MG BASE/ML N72786 001 Sep 24, 1991 Ma CAHN
>D> FLUDEOXYGLUCOSE, F-18
>D> INJECTABLE; INJECTION
>D> FLUDEOXYGLUCOSE F 18
>D> + DOWNSTATE CLINCL 4-90mCi/ML N20306 002 Sep 25, 2001 Ma DISC
>A> @ 4-90mCi/ML N20306 002 Sep 25, 2001 Ma DISC
FLUOXETINE HYDROCHLORIDE
SOLUTION; ORAL
FLUOXETINE HCL
>A> AA PAR PHARM EQ 20MG BASE/5ML N76458 001 May 14, 2004 Ma NEWA
FLUTICASONE PROPIONATE
AEROSOL, METERED; INHALATION
>A> FLOVENT HFA
>A> GLAXOSMITHKLINE 0.044MG/INH N21433 003 May 14, 2004 Ma NEWA
>A> 0.11MG/INH N21433 002 May 14, 2004 Ma NEWA
>A> + 0.22MG/INH N21433 001 May 14, 2004 Ma NEWA
CREAM; TOPICAL
CUTIVATE
>D> + GLAXOSMITHKLINE 0.05% N19958 001 Dec 18, 1990 Ma CFTG
>A> AB + 0.05% N19958 001 Dec 18, 1990 Ma CFTG
>A> FLUTICASONE PROPIONATE
>A> AB ALTANA 0.05% N76451 001 May 14, 2004 Ma NEWA
>A> AB ATRIX 0.05% N76633 001 May 14, 2004 Ma NEWA
>A> AB CLAY PARK 0.05% N76793 001 May 14, 2004 Ma NEWA
OINTMENT; TOPICAL
CUTIVATE
>D> + GLAXOSMITHKLINE 0.005% N19957 001 Dec 14, 1990 Ma CFTG
>A> AB + 0.005% N19957 001 Dec 14, 1990 Ma CFTG
>A> FLUTICASONE PROPIONATE
>A> AB ALTANA 0.005% N76300 001 May 14, 2004 Ma NEWA
>A> AB CLAY PARK 0.005% N76668 001 May 14, 2004 Ma NEWA
FOLLITROPIN ALFA/BETA
INJECTABLE; SUBCUTANEOUS
GONAL-F
>D> SERONO INC 37.5 IU/VIAL N21765 001 Mar 25, 2004 Ma DISC
>A> @ 37.5 IU/VIAL N21765 001 Mar 25, 2004 Ma DISC
>D> + 150 IU/VIAL N21765 003 Mar 25, 2004 Ma DISC
>A> @ 150 IU/VIAL N21765 003 Mar 25, 2004 Ma DISC
>A> GONAL-F RFF PEN
>A> SERONO INC 300 IU/0.5ML N21684 001 May 25, 2004 Ma NEWA
>A> 450 IU/0.75ML N21684 002 May 25, 2004 Ma NEWA
>A> + 900 IU/1.5ML N21684 003 May 25, 2004 Ma NEWA
FONDAPARINUX SODIUM
INJECTABLE; SUBCUTANEOUS
ARIXTRA
>A> + FONDA BV 5MG/0.4ML N21345 002 May 28, 2004 Ma NEWA
>A> + 7.5MG/0.6ML N21345 003 May 28, 2004 Ma NEWA
>A> + 10MG/0.8ML N21345 004 May 28, 2004 Ma NEWA
FROVATRIPTAN SUCCINATE
TABLET; ORAL
FROVA
>D> + ELAN PHARMS EQ 2.5MG BASE N21006 001 Nov 08, 2001 Ma CAHN
>A> + VERNALIS EQ 2.5MG BASE N21006 001 Nov 08, 2001 Ma CAHN
FUROSEMIDE
INJECTABLE; INJECTION
FUROSEMIDE
>D> AP ABBOTT 10MG/ML N75241 001 May 28, 1999 Ma CAHN
>D> AP 10MG/ML N74337 001 Oct 31, 1994 Ma CAHN
>D> AP 10MG/ML N72080 001 Aug 13, 1991 Ma CAHN
>D> AP 10MG/ML N70578 001 Jul 08, 1987 Ma CAHN
>D> AP 10MG/ML N18667 001 May 28, 1982 Ma CAHN
>A> AP HOSPIRA 10MG/ML N75241 001 May 28, 1999 Ma CAHN
>A> AP 10MG/ML N74337 001 Oct 31, 1994 Ma CAHN
>A> AP 10MG/ML N72080 001 Aug 13, 1991 Ma CAHN
>A> AP 10MG/ML N70578 001 Jul 08, 1987 Ma CAHN
>A> AP 10MG/ML N18667 001 May 28, 1982 Ma CAHN
GENTAMICIN SULFATE
INJECTABLE; INJECTION
GENTAMICIN SULFATE
>D> AP ABBOTT EQ 10MG BASE/ML N62612 004 Feb 20, 1986 Ma CAHN
>D> AP EQ 10MG BASE/ML N62420 001 Aug 15, 1983 Ma CAHN
>D> AP EQ 40MG BASE/ML N62420 002 Aug 15, 1983 Ma CAHN
>A> AP HOSPIRA EQ 10MG BASE/ML N62612 004 Feb 20, 1986 Ma CAHN
>A> AP EQ 10MG BASE/ML N62420 001 Aug 15, 1983 Ma CAHN
>A> AP EQ 40MG BASE/ML N62420 002 Aug 15, 1983 Ma CAHN
GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
>D> @ ABBOTT EQ 1.2MG BASE/ML N62588 001 Jan 06, 1986 Ma CAHN
>D> AP EQ 1.2MG BASE/ML N62414 001 Aug 15, 1983 Ma CAHN
>D> @ EQ 1.4MG BASE/ML N62588 002 Jan 06, 1986 Ma CAHN
>D> AP EQ 1.4MG BASE/ML N62414 002 Aug 15, 1983 Ma CAHN
>D> @ EQ 1.6MG BASE/ML N62588 003 Jan 06, 1986 Ma CAHN
>D> AP EQ 1.6MG BASE/ML N62414 003 Aug 15, 1983 Ma CAHN
>D> @ EQ 1.8MG BASE/ML N62588 004 Jan 06, 1986 Ma CAHN
>D> AP EQ 1.8MG BASE/ML N62414 004 Aug 15, 1983 Ma CAHN
>D> @ EQ 2MG BASE/ML N62588 005 Jan 06, 1986 Ma CAHN
>D> AP EQ 2MG BASE/ML N62414 005 Aug 15, 1983 Ma CAHN
>D> @ ABBOTT EQ 60MG BASE/100ML N62588 006 Jan 06, 1986 Ma CAHN
>D> AP EQ 60MG BASE/100ML N62414 006 Aug 15, 1983 Ma CAHN
>D> @ EQ 70MG BASE/100ML N62588 007 Jan 06, 1986 Ma CAHN
>D> AP EQ 70MG BASE/100ML N62414 007 Aug 15, 1983 Ma CAHN
>D> @ EQ 80MG BASE/100ML N62588 008 Jan 06, 1986 Ma CAHN
>D> AP EQ 80MG BASE/100ML N62414 008 Aug 15, 1983 Ma CAHN
>D> @ EQ 90MG BASE/100ML N62588 009 Jan 06, 1986 Ma CAHN
>D> AP EQ 90MG BASE/100ML N62414 009 Aug 15, 1983 Ma CAHN
>D> @ EQ 100MG BASE/100ML N62588 010 Jan 06, 1986 Ma CAHN
>D> AP EQ 100MG BASE/100ML N62414 010 Aug 15, 1983 Ma CAHN
>A> @ HOSPIRA EQ 1.2MG BASE/ML N62588 001 Jan 06, 1986 Ma CAHN
>A> AP EQ 1.2MG BASE/ML N62414 001 Aug 15, 1983 Ma CAHN
>A> @ EQ 1.4MG BASE/ML N62588 002 Jan 06, 1986 Ma CAHN
>A> AP EQ 1.4MG BASE/ML N62414 002 Aug 15, 1983 Ma CAHN
>A> @ EQ 1.6MG BASE/ML N62588 003 Jan 06, 1986 Ma CAHN
>A> AP EQ 1.6MG BASE/ML N62414 003 Aug 15, 1983 Ma CAHN
>A> @ EQ 1.8MG BASE/ML N62588 004 Jan 06, 1986 Ma CAHN
>A> AP EQ 1.8MG BASE/ML N62414 004 Aug 15, 1983 Ma CAHN
>A> @ EQ 2MG BASE/ML N62588 005 Jan 06, 1986 Ma CAHN
>A> AP EQ 2MG BASE/ML N62414 005 Aug 15, 1983 Ma CAHN
>A> @ EQ 60MG BASE/100ML N62588 006 Jan 06, 1986 Ma CAHN
>A> AP EQ 60MG BASE/100ML N62414 006 Aug 15, 1983 Ma CAHN
>A> @ EQ 70MG BASE/100ML N62588 007 Jan 06, 1986 Ma CAHN
>A> AP EQ 70MG BASE/100ML N62414 007 Aug 15, 1983 Ma CAHN
>A> @ EQ 80MG BASE/100ML N62588 008 Jan 06, 1986 Ma CAHN
>A> AP EQ 80MG BASE/100ML N62414 008 Aug 15, 1983 Ma CAHN
>A> @ EQ 90MG BASE/100ML N62588 009 Jan 06, 1986 Ma CAHN
>A> AP EQ 90MG BASE/100ML N62414 009 Aug 15, 1983 Ma CAHN
>A> @ EQ 100MG BASE/100ML N62588 010 Jan 06, 1986 Ma CAHN
>A> AP EQ 100MG BASE/100ML N62414 010 Aug 15, 1983 Ma CAHN
GLYCINE
SOLUTION; IRRIGATION
GLYCINE 1.5% IN PLASTIC CONTAINER
>D> AT ABBOTT 1.5GM/100ML N18315 001 Ma CAHN
>D> AT 1.5GM/100ML N17633 001 Ma CAHN
>A> AT HOSPIRA 1.5GM/100ML N18315 001 Ma CAHN
>A> AT 1.5GM/100ML N17633 001 Ma CAHN
GLYCOPYRROLATE
INJECTABLE; INJECTION
GLYCOPYRROLATE
>D> @ ABBOTT 0.2MG/ML N89393 001 Jun 15, 1988 Ma CAHN
>A> @ HOSPIRA 0.2MG/ML N89393 001 Jun 15, 1988 Ma CAHN
HALOTHANE
LIQUID; INHALATION
HALOTHANE
>D> AN + ABBOTT 99.99% N83254 001 Ma CAHN
>A> AN + HOSPIRA 99.99% N83254 001 Ma CAHN
HEPARIN SODIUM
INJECTABLE; INJECTION
HEPARIN LOCK FLUSH
>D> AP ABBOTT 10 UNITS/ML N88346 001 May 18, 1983 Ma CAHN
>D> AP 10 UNITS/ML N88097 001 Apr 28, 1983 Ma CAHN
>D> AP 10 UNITS/ML N40082 001 Feb 28, 1995 Ma CAHN
>D> AP 10 UNITS/ML N05264 001 Ma CAHN
>D> AP 100 UNITS/ML N88347 001 May 18, 1983 Ma CAHN
>D> AP 100 UNITS/ML N88098 001 Apr 28, 1983 Ma CAHN
>D> AP 100 UNITS/ML N40082 002 Feb 28, 1995 Ma CAHN
>D> @ 100 UNITS/ML N05264 010 Ma CAHN
>A> AP HOSPIRA 10 UNITS/ML N88346 001 May 18, 1983 Ma CAHN
>A> AP 10 UNITS/ML N88097 001 Apr 28, 1983 Ma CAHN
>A> AP 10 UNITS/ML N40082 001 Feb 28, 1995 Ma CAHN
>A> AP 10 UNITS/ML N05264 001 Ma CAHN
>A> AP 100 UNITS/ML N88347 001 May 18, 1983 Ma CAHN
>A> AP 100 UNITS/ML N88098 001 Apr 28, 1983 Ma CAHN
>A> AP 100 UNITS/ML N40082 002 Feb 28, 1995 Ma CAHN
>A> @ HOSPIRA 100 UNITS/ML N05264 010 Ma CAHN
HEPARIN LOCK FLUSH IN PLASTIC CONTAINER
>D> AP ABBOTT 10 UNITS/ML N05264 015 May 21, 1985 Ma CAHN
>D> AP 100 UNITS/ML N05264 016 May 21, 1985 Ma CAHN
>A> AP HOSPIRA 10 UNITS/ML N05264 015 May 21, 1985 Ma CAHN
>A> AP 100 UNITS/ML N05264 016 May 21, 1985 Ma CAHN
HEPARIN SODIUM
>D> AP + ABBOTT 2,500 UNITS/ML N88099 001 Apr 28, 1983 Ma CAHN
>D> AP 5,000 UNITS/ML N88100 001 Apr 28, 1983 Ma CAHN
>D> @ 10,000 UNITS/ML N40095 001 Jul 26, 1996 Ma CAHN
>A> AP + HOSPIRA 2,500 UNITS/ML N88099 001 Apr 28, 1983 Ma CAHN
>A> AP 5,000 UNITS/ML N88100 001 Apr 28, 1983 Ma CAHN
>A> @ 10,000 UNITS/ML N40095 001 Jul 26, 1996 Ma CAHN
HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
>D> AP ABBOTT 200 UNITS/100ML N18916 010 Jun 23, 1989 Ma CAHN
>A> AP HOSPIRA 200 UNITS/100ML N18916 010 Jun 23, 1989 Ma CAHN
HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5%
>D> @ ABBOTT 10,000 UNITS/100ML N18911 006 Jan 30, 1985 Ma CAHN
>A> @ HOSPIRA 10,000 UNITS/100ML N18911 006 Jan 30, 1985 Ma CAHN
HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> AP ABBOTT 10,000 UNITS/100ML N19339 003 Mar 27, 1985 Ma CAHN
>A> AP HOSPIRA 10,000 UNITS/100ML N19339 003 Mar 27, 1985 Ma CAHN
HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.45%
>D> @ ABBOTT 10,000 UNITS/100ML N18916 005 Jan 31, 1984 Ma CAHN
>D> @ 10,000 UNITS/100ML N18911 001 Jan 30, 1985 Ma CAHN
>A> @ HOSPIRA 10,000 UNITS/100ML N18916 005 Jan 31, 1984 Ma CAHN
>A> @ 10,000 UNITS/100ML N18911 001 Jan 30, 1985 Ma CAHN
HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9%
>D> @ ABBOTT 10,000 UNITS/100ML N18916 002 Jan 31, 1984 Ma CAHN
>D> @ 10,000 UNITS/100ML N18911 003 Jan 30, 1985 Ma CAHN
>A> @ HOSPIRA 10,000 UNITS/100ML N18916 002 Jan 31, 1984 Ma CAHN
>A> @ 10,000 UNITS/100ML N18911 003 Jan 30, 1985 Ma CAHN
HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5%
>D> @ ABBOTT 5,000 UNITS/100ML N18911 007 Jan 30, 1985 Ma CAHN
>A> @ HOSPIRA 5,000 UNITS/100ML N18911 007 Jan 30, 1985 Ma CAHN
HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> ABBOTT 5,000 UNITS/100ML N19339 001 Mar 27, 1985 Ma CAHN
>A> HOSPIRA 5,000 UNITS/100ML N19339 001 Mar 27, 1985 Ma CAHN
HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
>D> ABBOTT 5,000 UNITS/100ML N18916 006 Jan 31, 1984 Ma CAHN
>A> HOSPIRA 5,000 UNITS/100ML N18916 006 Jan 31, 1984 Ma CAHN
HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.9%
>D> @ ABBOTT 5,000 UNITS/100ML N18916 003 Jan 31, 1984 Ma CAHN
>D> @ 5,000 UNITS/100ML N18911 005 Jan 30, 1985 Ma CAHN
>A> @ HOSPIRA 5,000 UNITS/100ML N18916 003 Jan 31, 1984 Ma CAHN
>A> @ 5,000 UNITS/100ML N18911 005 Jan 30, 1985 Ma CAHN
HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
>D> AP ABBOTT 200 UNITS/100ML N18916 011 Jun 23, 1989 Ma CAHN
>A> AP HOSPIRA 200 UNITS/100ML N18916 011 Jun 23, 1989 Ma CAHN
HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> AP ABBOTT 4,000 UNITS/100ML N19805 001 Jan 25, 1989 Ma CAHN
>A> AP HOSPIRA 4,000 UNITS/100ML N19805 001 Jan 25, 1989 Ma CAHN
HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5%
>D> @ ABBOTT 5,000 UNITS/100ML N18911 009 Jan 30, 1985 Ma CAHN
>D> @ 10,000 UNITS/100ML N18911 008 Jan 30, 1985 Ma CAHN
>A> @ HOSPIRA 5,000 UNITS/100ML N18911 009 Jan 30, 1985 Ma CAHN
>A> @ 10,000 UNITS/100ML N18911 008 Jan 30, 1985 Ma CAHN
HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> AP ABBOTT 5,000 UNITS/100ML N19805 002 Jan 25, 1989 Ma CAHN
>D> AP 5,000 UNITS/100ML N19339 004 Mar 27, 1985 Ma CAHN
>D> AP 10,000 UNITS/100ML N19339 002 Mar 27, 1985 Ma CAHN
>A> AP HOSPIRA 5,000 UNITS/100ML N19805 002 Jan 25, 1989 Ma CAHN
>A> AP 5,000 UNITS/100ML N19339 004 Mar 27, 1985 Ma CAHN
>A> AP 10,000 UNITS/100ML N19339 002 Mar 27, 1985 Ma CAHN
HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
>D> ABBOTT 5,000 UNITS/100ML N18916 007 Jan 31, 1984 Ma CAHN
>D> 10,000 UNITS/100ML N18916 008 Jan 31, 1984 Ma CAHN
>A> HOSPIRA 5,000 UNITS/100ML N18916 007 Jan 31, 1984 Ma CAHN
>A> 10,000 UNITS/100ML N18916 008 Jan 31, 1984 Ma CAHN
HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9%
>D> @ ABBOTT 5,000 UNITS/100ML N18911 004 Jan 30, 1985 Ma CAHN
>A> @ HOSPIRA 5,000 UNITS/100ML N18911 004 Jan 30, 1985 Ma CAHN
HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
>D> @ ABBOTT 5,000 UNITS/100ML N18916 009 Jan 31, 1984 Ma CAHN
>A> @ HOSPIRA 5,000 UNITS/100ML N18916 009 Jan 31, 1984 Ma CAHN
HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.45%
>D> @ ABBOTT 100 UNITS/ML N18916 004 Jan 31, 1984 Ma CAHN
>D> @ 100 UNITS/ML N18911 002 Jan 30, 1985 Ma CAHN
>A> @ HOSPIRA 100 UNITS/ML N18916 004 Jan 31, 1984 Ma CAHN
>A> @ 100 UNITS/ML N18911 002 Jan 30, 1985 Ma CAHN
HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9%
>D> @ ABBOTT 1,000 UNITS/100ML N18916 001 Jan 31, 1984 Ma CAHN
>A> @ HOSPIRA 1,000 UNITS/100ML N18916 001 Jan 31, 1984 Ma CAHN
HEPARIN SODIUM PRESERVATIVE FREE
>D> + ABBOTT 2,000 UNITS/ML N05264 013 Apr 07, 1986 Ma CAHN
>D> AP + 2,500 UNITS/ML N05264 014 Apr 07, 1986 Ma CAHN
>D> AP + 10,000 UNITS/ML N89522 001 May 04, 1987 Ma CAHN
>A> + HOSPIRA 2,000 UNITS/ML N05264 013 Apr 07, 1986 Ma CAHN
>A> AP + 2,500 UNITS/ML N05264 014 Apr 07, 1986 Ma CAHN
>A> AP + 10,000 UNITS/ML N89522 001 May 04, 1987 Ma CAHN
PANHEPRIN
>D> @ ABBOTT 1,000 UNITS/ML N05264 004 Ma CAHN
>D> @ 5,000 UNITS/ML N05264 006 Ma CAHN
>D> @ 10,000 UNITS/ML N05264 007 Ma CAHN
>D> @ 20,000 UNITS/ML N05264 008 Ma CAHN
>D> @ 40,000 UNITS/ML N05264 009 Ma CAHN
>A> @ HOSPIRA 1,000 UNITS/ML N05264 004 Ma CAHN
>A> @ 5,000 UNITS/ML N05264 006 Ma CAHN
>A> @ 10,000 UNITS/ML N05264 007 Ma CAHN
>A> @ 20,000 UNITS/ML N05264 008 Ma CAHN
>A> @ 40,000 UNITS/ML N05264 009 Ma CAHN
>A> HYALURONIDASE
>A> INJECTABLE; INJECTION
>A> VITRASE
>A> + ISTA PHARMS 6,200 UNITS/VIAL N21640 001 May 05, 2004 Ma NEWA
HYTABLET; ORAL
>D> + MIBOEHRINGER 12.5MG;80MG N21162 002 Nov 17, 2000 Ma CRLD
>A> 12.5MG;80MG N21162 002 Nov 17, 2000 Ma CRLD
>A> + 25MG;80MG N21162 003 Apr 19, 2004 Ma NEWA
HYDROCORTISONE SODIUM SUCCINATE
INJECTABLE; INJECTION
A-HYDROCORT
>D> AP ABBOTT EQ 100MG BASE/VIAL N85929 001 Ma CAHN
>D> AP EQ 250MG BASE/VIAL N85930 001 Ma CAHN
>D> AP EQ 500MG BASE/VIAL N85931 001 Ma CAHN
>D> AP EQ 1GM BASE/VIAL N85932 001 Ma CAHN
>A> AP HOSPIRA EQ 100MG BASE/VIAL N85929 001 Ma CAHN
>A> AP EQ 250MG BASE/VIAL N85930 001 Ma CAHN
>A> AP EQ 500MG BASE/VIAL N85931 001 Ma CAHN
>A> AP EQ 1GM BASE/VIAL N85932 001 Ma CAHN
HYDROMORPHONE HYDROCHLORIDE
INJECTABLE; INJECTION
HYDROMORPHONE HCL
>D> AP ABBOTT 10MG/ML N74598 001 Jun 19, 1997 Ma CAHN
>A> AP HOSPIRA 10MG/ML N74598 001 Jun 19, 1997 Ma CAHN
HYDROXYZINE HYDROCHLORIDE
INJECTABLE; INJECTION
HYDROXYZINE HCL
>D> AP ABBOTT 25MG/ML N87416 001 Ma CAHN
>D> AP 50MG/ML N87546 001 Ma CAHN
>D> @ 50MG/ML N86821 001 Ma CAHN
>A> AP HOSPIRA 25MG/ML N87416 001 Ma CAHN
>A> AP HOSPIRA 50MG/ML N87546 001 Ma CAHN
>A> @ 50MG/ML N86821 001 Ma CAHN
INAMRINONE LACTATE
INJECTABLE; INJECTION
AMRINONE
>D> AP + ABBOTT EQ 5MG BASE/ML N74616 001 Aug 03, 1998 Ma CAHN
>A> AP + HOSPIRA EQ 5MG BASE/ML N74616 001 Aug 03, 1998 Ma CAHN
>D> INSULIN ASPART
>D> INJECTABLE; SUBCUTANEOUS
>D> NOVOLOG
>D> + NOVO NORDISK 100 UNITS/ML N20986 001 Jun 07, 2000 Ma CAIN
>A> INSULIN ASPART RECOMBINANT
>A> INJECTABLE; SUBCUTANEOUS
>A> NOVOLOG
>A> + NOVO NORDISK 100 UNITS/ML N20986 001 Jun 07, 2000 Ma CAIN
>D> INSULIN GLARGINE
>D> INJECTABLE; INJECTION
>D> LANTUS
>D> + AVENTIS PHARMS 100 UNITS/ML N21081 001 Apr 20, 2000 Ma CAIN
>A> INSULIN GLARGINE RECOMBINANT
>A> INJECTABLE; INJECTION
>A> LANTUS
>A> + AVENTIS PHARMS 100 UNITS/ML N21081 001 Apr 20, 2000 Ma CAIN
>D> INSULIN LISPRO
>D> INJECTABLE; INJECTION
>D> HUMALOG
>D> + LILLY 100 UNITS/ML N20563 001 Jun 14, 1996 Ma CAIN
>D> HUMALOG PEN
>D> + LILLY 100 UNITS/ML N20563 002 Aug 06, 1998 Ma CAIN
>A> INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT
>A> INJECTABLE; INJECTION
>A> HUMALOG MIX 50/50
>A> + LILLY 50 UNITS/ML;50 UNITS/ML N21018 001 Dec 22, 1999 Ma CAIN
>A> HUMALOG MIX 75/25
>A> + LILLY 75 UNITS/ML;25 UNITS/ML N21017 001 Dec 22, 1999 Ma CAIN
>A> INSULIN LISPRO RECOMBINANT
>A> INJECTABLE; INJECTION
>A> HUMALOG
>A> + LILLY 100 UNITS/ML N20563 001 Jun 14, 1996 Ma CAIN
>A> HUMALOG PEN
>A> + LILLY 100 UNITS/ML N20563 002 Aug 06, 1998 Ma CAIN
>D> INSULIN LISPRO; INSULIN LISPRO PROTAMINE
>D> INJECTABLE; INJECTION
>D> HUMALOG MIX 50/50
>D> + LILLY 50 UNITS/ML;50 UNITS/ML N21018 001 Dec 22, 1999 Ma CAIN
>D> HUMALOG MIX 75/25
>D> + LILLY 25 UNITS/ML;75 UNITS/ML N21017 001 Dec 22, 1999 Ma CAIN
IOPAMIDOL
INJECTABLE; INJECTION
IOPAMIDOL-200
>D> AP ABBOTT 41% N74898 001 Dec 30, 1997 Ma CAHN
>A> AP HOSPIRA 41% N74898 001 Dec 30, 1997 Ma CAHN
IOPAMIDOL-200 IN PLASTIC CONTAINER
>D> AP ABBOTT 41% N74636 001 Dec 30, 1997 Ma CAHN
>A> AP HOSPIRA 41% N74636 001 Dec 30, 1997 Ma CAHN
IOPAMIDOL-250
>D> AP ABBOTT 51% N75005 001 Feb 24, 1998 Ma CAHN
>D> AP 51% N74898 002 Dec 30, 1997 Ma CAHN
>A> AP HOSPIRA 51% N75005 001 Feb 24, 1998 Ma CAHN
>A> AP 51% N74898 002 Dec 30, 1997 Ma CAHN
IOPAMIDOL-250 IN PLASTIC CONTAINER
>D> AP ABBOTT 51% N74636 002 Dec 30, 1997 Ma CAHN
>A> AP HOSPIRA 51% N74636 002 Dec 30, 1997 Ma CAHN
IOPAMIDOL-300
>D> AP ABBOTT 61% N75005 002 Feb 24, 1998 Ma CAHN
>D> AP 61% N74898 003 Dec 30, 1997 Ma CAHN
>A> AP HOSPIRA 61% N75005 002 Feb 24, 1998 Ma CAHN
>A> AP 61% N74898 003 Dec 30, 1997 Ma CAHN
IOPAMIDOL-300 IN PLASTIC CONTAINER
>D> AP ABBOTT 61% N74637 001 Apr 03, 1997 Ma CAHN
>D> AP 61% N74636 003 Dec 30, 1997 Ma CAHN
>A> AP HOSPIRA 61% N74637 001 Apr 03, 1997 Ma CAHN
>A> AP 61% N74636 003 Dec 30, 1997 Ma CAHN
IOPAMIDOL-370
>D> AP ABBOTT 76% N75005 003 Feb 24, 1998 Ma CAHN
>D> AP 76% N74898 004 Dec 30, 1997 Ma CAHN
>A> AP HOSPIRA 76% N75005 003 Feb 24, 1998 Ma CAHN
>A> AP 76% N74898 004 Dec 30, 1997 Ma CAHN
IOPAMIDOL-370 IN PLASTIC CONTAINER
>D> AP ABBOTT 76% N74636 004 Dec 30, 1997 Ma CAHN
>A> AP HOSPIRA 76% N74636 004 Dec 30, 1997 Ma CAHN
>D> IOPANOIC ACID
>D> TABLET; ORAL
>D> TELEPAQUE
>D> + AMERSHAM HLTH 500MG N08032 001 Ma DISC
>A> @ GE HEALTHCARE 500MG N08032 001 Ma DISC
ISOFLURANE
LIQUID; INHALATION
ISOFLURANE
>D> AN ABBOTT 99.9% N74097 001 Jan 25, 1993 Ma CAHN
>A> AN HOSPIRA 99.9% N74097 001 Jan 25, 1993 Ma CAHN
ISOPROTERENOL HYDROCHLORIDE
INJECTABLE; INJECTION
ISOPROTERENOL HCL
>D> ABBOTT 0.02MG/ML N83283 001 Ma CAHN
>D> AP 0.2MG/ML N83346 001 Ma CAHN
>A> HOSPIRA 0.02MG/ML N83283 001 Ma CAHN
>A> AP 0.2MG/ML N83346 001 Ma CAHN
ISUPREL
>D> AP + ABBOTT 0.2MG/ML N10515 001 Ma CAHN
>A> AP + HOSPIRA 0.2MG/ML N10515 001 Ma CAHN
ITRACONAZOLE
CAPSULE; ORAL
>A> ITRACONAZOLE
>A> AB EON 100MG N76104 001 May 28, 2004 Ma NEWA
SPORANOX
>D> + JANSSEN PHARMA 100MG N20083 001 Sep 11, 1992 Ma CFTG
>A> AB + 100MG N20083 001 Sep 11, 1992 Ma CFTG
KETAMINE HYDROCHLORIDE
INJECTABLE; INJECTION
KETAMINE HCL
>D> AP ABBOTT EQ 50MG BASE/ML N74549 001 Jun 27, 1996 Ma CAHN
>D> AP EQ 100MG BASE/ML N74549 002 Jun 27, 1996 Ma CAHN
>A> AP HOSPIRA EQ 50MG BASE/ML N74549 001 Jun 27, 1996 Ma CAHN
>A> AP EQ 100MG BASE/ML N74549 002 Jun 27, 1996 Ma CAHN
KETOROLAC TROMETHAMINE
INJECTABLE; INJECTION
KETOROLAC TROMETHAMINE
>D> AP ABBOTT 15MG/ML N74993 001 Jan 27, 1999 Ma CAHN
>D> AP 15MG/ML N74802 001 Jun 05, 1997 Ma CAHN
>D> @ 15MG/ML N74801 001 Jun 05, 1997 Ma CAHN
>D> AP 30MG/ML N74993 002 Jan 27, 1999 Ma CAHN
>D> AP 30MG/ML N74802 002 Jun 05, 1997 Ma CAHN
>D> @ 30MG/ML N74801 002 Jun 05, 1997 Ma CAHN
>A> AP HOSPIRA 15MG/ML N74993 001 Jan 27, 1999 Ma CAHN
>A> AP HOSPIRA 15MG/ML N74802 001 Jun 05, 1997 Ma CAHN
>A> @ 15MG/ML N74801 001 Jun 05, 1997 Ma CAHN
>A> AP 30MG/ML N74993 002 Jan 27, 1999 Ma CAHN
>A> AP 30MG/ML N74802 002 Jun 05, 1997 Ma CAHN
>A> @ 30MG/ML N74801 002 Jun 05, 1997 Ma CAHN
LABETALOL HYDROCHLORIDE
INJECTABLE; INJECTION
LABETALOL HCL
>D> AP ABBOTT 5MG/ML N75240 001 Nov 29, 1999 Ma CAHN
>D> AP 5MG/ML N75239 001 Nov 29, 1999 Ma CAHN
>A> AP HOSPIRA 5MG/ML N75240 001 Nov 29, 1999 Ma CAHN
>A> AP 5MG/ML N75239 001 Nov 29, 1999 Ma CAHN
LAMIVUDINE
TABLET; ORAL
EPIVIR
>D> + GLAXOSMITHKLINE 150MG N20564 001 Nov 17, 1995 Ma CRLD
>A> 150MG N20564 001 Nov 17, 1995 Ma CRLD
>D> 300MG N20564 003 Jun 24, 2002 Ma CRLD
>A> + 300MG N20564 003 Jun 24, 2002 Ma CRLD
LANSOPRAZOLE
>A> INJECTABLE; INTRAVENOUS
>A> PREVACID IV
>A> + TAP PHARM 30MG/VIAL N21566 001 May 27, 2004 Ma NEWA
LEUCOVORIN CALCIUM
INJECTABLE; INJECTION
LEUCOVORIN CALCIUM PRESERVATIVE FREE
>D> AP + ABBOTT EQ 10MG BASE/ML N40147 001 Jun 25, 1997 Ma CAHN
>A> AP + HOSPIRA EQ 10MG BASE/ML N40147 001 Jun 25, 1997 Ma CAHN
>D> LEVOBUPIVACAINE HYDROCHLORIDE
>D> INJECTABLE; INJECTION
>D> CHIROCAINE
>D> PURDUE PHARMA LP EQ 2.5MG BASE/ML N20997 001 Aug 05, 1999 Ma DISC
>A> @ EQ 2.5MG BASE/ML N20997 001 Aug 05, 1999 Ma DISC
>D> EQ 5MG BASE/ML N20997 002 Aug 05, 1999 Ma DISC
>A> @ EQ 5MG BASE/ML N20997 002 Aug 05, 1999 Ma DISC
>D> + EQ 7.5MG BASE/ML N20997 003 Aug 05, 1999 Ma DISC
>A> @ EQ 7.5MG BASE/ML N20997 003 Aug 05, 1999 Ma DISC
LIDOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
LIDOCAINE HCL
>D> AP ABBOTT 0.5% N88328 001 May 17, 1984 Ma CAHN
>D> AP 1% N88329 001 May 17, 1984 Ma CAHN
>D> AP 1% N83158 001 Ma CAHN
>D> AP 1% N40013 001 Jun 23, 1995 Ma CAHN
>D> @ 1.5% N88330 001 May 17, 1984 Ma CAHN
>D> AP 2% N88331 001 May 17, 1984 Ma CAHN
>D> AP 2% N88294 001 May 17, 1984 Ma CAHN
>D> AP 2% N83158 002 Ma CAHN
>D> AP 2% N40078 001 Jun 23, 1995 Ma CAHN
>D> AP 20% N83158 003 Ma CAHN
>A> AP HOSPIRA 0.5% N88328 001 May 17, 1984 Ma CAHN
>A> AP 1% N88329 001 May 17, 1984 Ma CAHN
>A> AP 1% N83158 001 Ma CAHN
>A> AP 1% N40013 001 Jun 23, 1995 Ma CAHN
>A> @ 1.5% N88330 001 May 17, 1984 Ma CAHN
>A> AP 2% N88331 001 May 17, 1984 Ma CAHN
>A> AP 2% N88294 001 May 17, 1984 Ma CAHN
>A> AP 2% N83158 002 Ma CAHN
>A> AP 2% N40078 001 Jun 23, 1995 Ma CAHN
>A> AP 20% N83158 003 Ma CAHN
LIDOCAINE HCL 0.2% IN DEXTROSE 5%
>D> AP ABBOTT 200MG/100ML N83158 005 Ma CAHN
>A> AP HOSPIRA 200MG/100ML N83158 005 Ma CAHN
LIDOCAINE HCL 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> AP ABBOTT 200MG/100ML N18388 001 Ma CAHN
>A> AP HOSPIRA 200MG/100ML N18388 001 Ma CAHN
LIDOCAINE HCL 0.4% IN DEXTROSE 5%
>D> AP ABBOTT 400MG/100ML N83158 006 Ma CAHN
>A> AP HOSPIRA 400MG/100ML N83158 006 Ma CAHN
LIDOCAINE HCL 0.4% IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> AP ABBOTT 400MG/100ML N18388 002 Ma CAHN
>A> AP HOSPIRA 400MG/100ML N18388 002 Ma CAHN
LIDOCAINE HCL 0.8% IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> AP ABBOTT 800MG/100ML N18388 003 Nov 05, 1982 Ma CAHN
>A> AP HOSPIRA 800MG/100ML N18388 003 Nov 05, 1982 Ma CAHN
LIDOCAINE HCL IN PLASTIC CONTAINER
>D> AP ABBOTT 0.5% N88325 001 Jul 31, 1984 Ma CAHN
>D> AP 1% N88299 001 Jul 31, 1984 Ma CAHN
>D> AP 1.5% N88326 001 Jul 31, 1984 Ma CAHN
>D> AP 2% N88327 001 Jul 31, 1984 Ma CAHN
>D> AP 10% N88367 001 Jul 31, 1984 Ma CAHN
>D> AP 20% N88368 001 Jul 31, 1984 Ma CAHN
>A> AP HOSPIRA 0.5% N88325 001 Jul 31, 1984 Ma CAHN
>A> AP 1% N88299 001 Jul 31, 1984 Ma CAHN
>A> AP 1.5% N88326 001 Jul 31, 1984 Ma CAHN
>A> AP 2% N88327 001 Jul 31, 1984 Ma CAHN
>A> AP 10% N88367 001 Jul 31, 1984 Ma CAHN
>A> AP 20% N88368 001 Jul 31, 1984 Ma CAHN
LIDOCAINE HCL PRESERVATIVE FREE
>D> AP ABBOTT 1% N80408 001 Ma CAHN
>D> AP 1.5% N80408 002 Ma CAHN
>D> AP 4% N88295 001 May 17, 1984 Ma CAHN
>A> AP HOSPIRA 1% N80408 001 Ma CAHN
>A> AP 1.5% N80408 002 Ma CAHN
>A> AP 4% N88295 001 May 17, 1984 Ma CAHN
LIDOCAINE HCL PRESERVATIVE FREE IN PLASTIC CONTAINER
>D> AP ABBOTT 1% N40302 001 Sep 28, 1998 Ma CAHN
>D> AP 2% N40302 002 Sep 28, 1998 Ma CAHN
>A> AP HOSPIRA 1% N40302 001 Sep 28, 1998 Ma CAHN
>A> AP 2% N40302 002 Sep 28, 1998 Ma CAHN
INJECTABLE; SPINAL
LIDOCAINE HCL 5% AND DEXTROSE 7.5%
>D> + ABBOTT 5% N83914 001 Ma CAHN
>A> + HOSPIRA 5% N83914 001 Ma CAHN
SOLUTION; TOPICAL
LTA II KIT
>D> AT ABBOTT 4% N88542 001 Jul 31, 1984 Ma CAHN
>D> AT 4% N80409 001 Ma CAHN
>A> AT HOSPIRA 4% N88542 001 Jul 31, 1984 Ma CAHN
>A> AT 4% N80409 001 Ma CAHN
PEDIATRIC LTA KIT
>D> AT ABBOTT 2% N85995 001 Ma CAHN
>A> AT HOSPIRA 2% N85995 001 Ma CAHN
LORAZEPAM
INJECTABLE; INJECTION
LORAZEPAM
>D> AP ABBOTT 2MG/ML N74300 001 Apr 12, 1994 Ma CAHN
>D> AP 2MG/ML N74282 001 May 27, 1994 Ma CAHN
>D> AP 2MG/ML N74280 001 May 27, 1994 Ma CAHN
>D> AP 2MG/ML N74243 001 Apr 12, 1994 Ma CAHN
>D> AP 4MG/ML N74300 003 Mar 19, 1997 Ma CAHN
>D> AP 4MG/ML N74282 002 May 27, 1994 Ma CAHN
>D> AP 4MG/ML N74280 002 May 27, 1994 Ma CAHN
>D> AP 4MG/ML N74243 002 Apr 12, 1994 Ma CAHN
>A> AP HOSPIRA 2MG/ML N74300 001 Apr 12, 1994 Ma CAHN
>A> AP 2MG/ML N74282 001 May 27, 1994 Ma CAHN
>A> AP 2MG/ML N74280 001 May 27, 1994 Ma CAHN
>A> AP 2MG/ML N74243 001 Apr 12, 1994 Ma CAHN
>A> AP 4MG/ML N74300 003 Mar 19, 1997 Ma CAHN
>A> AP 4MG/ML N74282 002 May 27, 1994 Ma CAHN
>A> AP 4MG/ML N74280 002 May 27, 1994 Ma CAHN
>A> AP HOSPIRA 4MG/ML N74243 002 Apr 12, 1994 Ma CAHN
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM
INJECTABLE; INJECTION
NORMOSOL-R IN PLASTIC CONTAINER
>D> ABBOTT 30MG/100ML;37MG/100ML;222MG/100M N17586 001 Ma CAHN
L;526MG/100ML;502MG/100ML
>A> HOSPIRA 30MG/100ML;37MG/100ML;222MG/100M N17586 001 Ma CAHN
L;526MG/100ML;502MG/100ML
SOLUTION; IRRIGATION
PHYSIOSOL IN PLASTIC CONTAINER
>D> @ ABBOTT 14MG/100ML;37MG/100ML;222MG/100M N18406 001 Ma CAHN
L;526MG/100ML;502MG/100ML
>D> 30MG/100ML;37MG/100ML;222MG/100M N17637 002 Jul 08, 1982 Ma CAHN
L;526MG/100ML;502MG/100ML
>A> @ HOSPIRA 14MG/100ML;37MG/100ML;222MG/100M N18406 001 Ma CAHN
L;526MG/100ML;502MG/100ML
>A> 30MG/100ML;37MG/100ML;222MG/100M N17637 002 Jul 08, 1982 Ma CAHN
L;526MG/100ML;502MG/100ML
PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER
>D> ABBOTT 30MG/100ML;37MG/100ML;222MG/100M N18406 002 Jul 08, 1982 Ma CAHN
L;526MG/100ML;502MG/100ML
>A> HOSPIRA 30MG/100ML;37MG/100ML;222MG/100M N18406 002 Jul 08, 1982 Ma CAHN
L;526MG/100ML;502MG/100ML
MAGNESIUM SULFATE
INJECTABLE; INJECTION
MAGNESIUM SULFATE
>D> AP ABBOTT 500MG/ML N75151 001 Apr 25, 2000 Ma CAHN
>A> AP HOSPIRA 500MG/ML N75151 001 Apr 25, 2000 Ma CAHN
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> + ABBOTT 1GM/100ML N20488 001 Jul 11, 1995 Ma CAHN
>D> + 2GM/100ML N20488 002 Jul 11, 1995 Ma CAHN
>A> + HOSPIRA 1GM/100ML N20488 001 Jul 11, 1995 Ma CAHN
>A> + 2GM/100ML N20488 002 Jul 11, 1995 Ma CAHN
MAGNESIUM SULFATE IN PLASTIC CONTAINER
>D> + ABBOTT 80MG/ML N20309 002 Jun 24, 1994 Ma CAHN
>D> + 4GM/100ML N20309 001 Jun 24, 1994 Ma CAHN
>A> + HOSPIRA 80MG/ML N20309 002 Jun 24, 1994 Ma CAHN
>A> + 4GM/100ML N20309 001 Jun 24, 1994 Ma CAHN
MANGANESE CHLORIDE
INJECTABLE; INJECTION
MANGANESE CHLORIDE IN PLASTIC CONTAINER
>D> ABBOTT EQ 0.1MG MANGANESE/ML N18962 001 Jun 26, 1986 Ma CAHN
>A> HOSPIRA EQ 0.1MG MANGANESE/ML N18962 001 Jun 26, 1986 Ma CAHN
MANNITOL
INJECTABLE; INJECTION
MANNITOL 10%
>D> @ ABBOTT 10GM/100ML N16269 002 Ma CAHN
>A> @ HOSPIRA 10GM/100ML N16269 002 Ma CAHN
MANNITOL 10% IN PLASTIC CONTAINER
>D> AP ABBOTT 10GM/100ML N19603 002 Jan 08, 1987 Ma CAHN
>A> AP HOSPIRA 10GM/100ML N19603 002 Jan 08, 1987 Ma CAHN
MANNITOL 15%
>D> @ ABBOTT 15GM/100ML N16269 003 Ma CAHN
>A> @ HOSPIRA 15GM/100ML N16269 003 Ma CAHN
MANNITOL 15% IN PLASTIC CONTAINER
>D> AP ABBOTT 15GM/100ML N19603 003 Jan 08, 1990 Ma CAHN
>A> AP HOSPIRA 15GM/100ML N19603 003 Jan 08, 1990 Ma CAHN
MANNITOL 20%
>D> @ ABBOTT 20GM/100ML N16269 004 Ma CAHN
>A> @ HOSPIRA 20GM/100ML N16269 004 Ma CAHN
MANNITOL 20% IN PLASTIC CONTAINER
>D> AP ABBOTT 20GM/100ML N19603 004 Jan 08, 1990 Ma CAHN
>A> AP HOSPIRA 20GM/100ML N19603 004 Jan 08, 1990 Ma CAHN
MANNITOL 25%
>D> @ ABBOTT 12.5GM/50ML N16269 005 Ma CAHN
>D> AP 12.5GM/50ML N16269 006 Aug 25, 1994 Ma CAHN
>A> @ HOSPIRA 12.5GM/50ML N16269 005 Ma CAHN
>A> AP 12.5GM/50ML N16269 006 Aug 25, 1994 Ma CAHN
MANNITOL 5%
>D> @ ABBOTT 5GM/100ML N16269 001 Ma CAHN
>A> @ HOSPIRA 5GM/100ML N16269 001 Ma CAHN
MANNITOL 5% IN PLASTIC CONTAINER
>D> AP ABBOTT 5GM/100ML N19603 001 Jan 08, 1987 Ma CAHN
>A> AP HOSPIRA 5GM/100ML N19603 001 Jan 08, 1987 Ma CAHN
MANNITOL; SORBITOL
SOLUTION; IRRIGATION
SORBITOL-MANNITOL
>D> @ ABBOTT 540MG/100ML;2.7GM/100ML N80224 001 Ma CAHN
>A> @ HOSPIRA 540MG/100ML;2.7GM/100ML N80224 001 Ma CAHN
SORBITOL-MANNITOL IN PLASTIC CONTAINER
>D> AT ABBOTT 540MG/100ML;2.7GM/100ML N18316 001 Ma CAHN
>D> AT 540MG/100ML;2.7GM/100ML N17636 001 Ma CAHN
>A> AT HOSPIRA 540MG/100ML;2.7GM/100ML N18316 001 Ma CAHN
>A> AT 540MG/100ML;2.7GM/100ML N17636 001 Ma CAHN
MENOTROPINS (FSH;LH)
INJECTABLE; INJECTION
>D> PERGONAL
>D> BX + SERONO 75 IU/AMP;75 IU/AMP N17646 001 Ma DISC
>A> @ 75 IU/AMP;75 IU/AMP N17646 001 Ma DISC
REPRONEX
>D> BX + FERRING 75 IU/VIAL;75 IU/VIAL N21047 001 Aug 27, 1999 Ma CTEC
>A> + 75 IU/VIAL;75 IU/VIAL N21047 001 Aug 27, 1999 Ma CTEC
MEPERIDINE HYDROCHLORIDE
INJECTABLE; INJECTION
DEMEROL
>D> AP + ABBOTT 25MG/ML N21171 001 Ma CAHN
>D> AP + 50MG/ML N21171 002 Ma CAHN
>D> AP + 75MG/ML N21171 003 Ma CAHN
>D> AP + 100MG/ML N21171 004 Ma CAHN
>A> AP + HOSPIRA 25MG/ML N21171 001 Ma CAHN
>A> AP + 50MG/ML N21171 002 Ma CAHN
>A> AP + 75MG/ML N21171 003 Ma CAHN
>A> AP + 100MG/ML N21171 004 Ma CAHN
MEPERIDINE HCL PRESERVATIVE FREE
>D> AP + ABBOTT 10MG/ML N88432 001 Aug 16, 1984 Ma CAHN
>A> AP + HOSPIRA 10MG/ML N88432 001 Aug 16, 1984 Ma CAHN
MEPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION
CARBOCAINE
>A> AP + HOSPIRA 1% N12250 001 Ma CAHN
>A> AP + 1.5% N12250 005 Ma CAHN
>A> AP + 2% N12250 002 Ma CAHN
>D> AP + STERLING WINTHROP 1% N12250 001 Ma CAHN
>D> AP + 1.5% N12250 005 Ma CAHN
>D> AP + 2% N12250 002 Ma CAHN
>D> MESORIDAZINE BESYLATE
>D> CONCENTRATE; ORAL
>D> SERENTIL
>D> + NOVARTIS EQ 25MG BASE/ML N16997 001 Ma DISC
>A> @ EQ 25MG BASE/ML N16997 001 Ma DISC
>D> TABLET; ORAL
>D> SERENTIL
>D> NOVARTIS EQ 25MG BASE N16774 002 Ma DISC
>A> @ EQ 25MG BASE N16774 002 Ma DISC
>D> + EQ 100MG BASE N16774 004 Ma DISC
>A> @ EQ 100MG BASE N16774 004 Ma DISC
METHYLDOPATE HYDROCHLORIDE
INJECTABLE; INJECTION
METHYLDOPATE HCL
>D> AP ABBOTT 50MG/ML N70699 001 Jun 15, 1987 Ma CAHN
>D> AP 50MG/ML N70698 001 Jun 15, 1987 Ma CAHN
>A> AP HOSPIRA 50MG/ML N70699 001 Jun 15, 1987 Ma CAHN
>A> AP HOSPIRA 50MG/ML N70698 001 Jun 15, 1987 Ma CAHN
METHYLPHENIDATE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL
METADATE CD
>D> CELLTECH PHARMS 10MG N21259 003 May 27, 2003 Ma CTEC
>A> BX 10MG N21259 003 May 27, 2003 Ma CTEC
RITALIN LA
>D> NOVARTIS 10MG N21284 004 Apr 10, 2004 Ma CTEC
>A> BX 10MG N21284 004 Apr 10, 2004 Ma CTEC
METHYLPREDNISOLONE SODIUM SUCCINATE
INJECTABLE; INJECTION
A-METHAPRED
>D> AP ABBOTT EQ 40MG BASE/VIAL N85853 001 Ma CAHN
>D> AP EQ 125MG BASE/VIAL N85855 001 Ma CAHN
>D> AP EQ 500MG BASE/VIAL N89173 001 Aug 18, 1987 Ma CAHN
>D> AP EQ 500MG BASE/VIAL N85854 001 Ma CAHN
>D> AP EQ 1GM BASE/VIAL N89174 001 Aug 18, 1987 Ma CAHN
>D> AP EQ 1GM BASE/VIAL N85852 001 Ma CAHN
>A> AP HOSPIRA EQ 40MG BASE/VIAL N85853 001 Ma CAHN
>A> AP EQ 125MG BASE/VIAL N85855 001 Ma CAHN
>A> AP EQ 500MG BASE/VIAL N89173 001 Aug 18, 1987 Ma CAHN
>A> AP EQ 500MG BASE/VIAL N85854 001 Ma CAHN
>A> AP EQ 1GM BASE/VIAL N89174 001 Aug 18, 1987 Ma CAHN
>A> AP EQ 1GM BASE/VIAL N85852 001 Ma CAHN
METOCLOPRAMIDE HYDROCHLORIDE
INJECTABLE; INJECTION
METOCLOPRAMIDE HCL
>D> AP ABBOTT EQ 5MG BASE/ML N74147 001 Aug 02, 1996 Ma CAHN
>D> AP EQ 5MG BASE/ML N73118 001 Jan 17, 1991 Ma CAHN
>D> AP EQ 5MG BASE/ML N73117 001 Jan 17, 1991 Ma CAHN
>D> @ EQ 5MG BASE/ML N70506 001 Jun 22, 1989 Ma CAHN
>D> AP EQ 5MG BASE/ML N70505 001 Jun 23, 1989 Ma CAHN
>A> AP HOSPIRA EQ 5MG BASE/ML N74147 001 Aug 02, 1996 Ma CAHN
>A> AP EQ 5MG BASE/ML N73118 001 Jan 17, 1991 Ma CAHN
>A> AP EQ 5MG BASE/ML N73117 001 Jan 17, 1991 Ma CAHN
>A> @ EQ 5MG BASE/ML N70506 001 Jun 22, 1989 Ma CAHN
>A> AP EQ 5MG BASE/ML N70505 001 Jun 23, 1989 Ma CAHN
METOPROLOL TARTRATE
INJECTABLE; INJECTION
METOPROLOL TARTRATE
>D> AP ABBOTT 1MG/ML N75160 001 Jul 06, 1998 Ma CAHN
>D> AP 1MG/ML N74133 001 Dec 21, 1993 Ma CAHN
>A> AP HOSPIRA 1MG/ML N75160 001 Jul 06, 1998 Ma CAHN
>A> AP 1MG/ML N74133 001 Dec 21, 1993 Ma CAHN
METRONIDAZOLE
CREAM; TOPICAL
METROCREAM
>D> + GALDERMA LABS LP 0.75% N20531 001 Sep 20, 1995 Ma CFTG
>A> AB + 0.75% N20531 001 Sep 20, 1995 Ma CFTG
>A> METRONIDAZOLE
>A> AB ALTANA 0.75% N76408 001 May 28, 2004 Ma NEWA
INJECTABLE; INJECTION
METRONIDAZOLE IN PLASTIC CONTAINER
>D> AP + ABBOTT 500MG/100ML N18890 002 Nov 18, 1983 Ma CAHN
>A> AP + HOSPIRA 500MG/100ML N18890 002 Nov 18, 1983 Ma CAHN
MIDAZOLAM HYDROCHLORIDE
INJECTABLE; INJECTION
MIDAZOLAM HCL
>D> AP ABBOTT EQ 1MG BASE/ML N75857 001 Jul 22, 2002 Ma CAHN
>D> AP EQ 1MG BASE/ML N75409 002 Jun 20, 2000 Ma CAHN
>D> AP + EQ 1MG BASE/ML N75293 001 Jun 20, 2000 Ma DISC
>D> AP EQ 5MG BASE/ML N75857 002 Jul 22, 2002 Ma CAHN
>D> AP EQ 5MG BASE/ML N75409 001 Jun 20, 2000 Ma CAHN
>D> AP + EQ 5MG BASE/ML N75293 002 Jun 20, 2000 Ma DISC
>A> AP + HOSPIRA EQ 1MG BASE/ML N75857 001 Jul 22, 2002 Ma CAHN
>A> AP EQ 1MG BASE/ML N75856 001 Jun 13, 2002 Ma CAHN
>A> AP EQ 1MG BASE/ML N75409 002 Jun 20, 2000 Ma CAHN
>A> @ EQ 1MG BASE/ML N75293 001 Jun 20, 2000 Ma DISC
>A> AP + EQ 5MG BASE/ML N75857 002 Jul 22, 2002 Ma CAHN
>A> AP EQ 5MG BASE/ML N75856 002 Jun 13, 2002 Ma CAHN
>A> AP EQ 5MG BASE/ML N75409 001 Jun 20, 2000 Ma CAHN
>A> @ EQ 5MG BASE/ML N75293 002 Jun 20, 2000 Ma DISC
>D> AP ROSS LABS EQ 1MG BASE/ML N75856 001 Jun 13, 2002 Ma CAHN
>D> AP EQ 5MG BASE/ML N75856 002 Jun 13, 2002 Ma CAHN
MIDODRINE HYDROCHLORIDE
TABLET; ORAL
MIDODRINE HCL
>A> AB IMPAX PHARMS 2.5MG N76449 001 May 27, 2004 Ma NEWA
>A> AB 5MG N76449 002 May 27, 2004 Ma NEWA
MILRINONE LACTATE
INJECTABLE; INJECTION
MILRINONE LACTATE
>D> AP HOSPIRA EQ 1MG BASE/ML N75884 001 May 28, 2002 Ma CAHN
>A> AP EQ 1MG BASE/ML N75884 001 May 28, 2002 Ma CAHN
MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> AP ABBOTT EQ 20MG BASE/100ML N75885 001 May 28, 2002 Ma CAHN
>A> AP HOSPIRA EQ 20MG BASE/100ML N75885 001 May 28, 2002 Ma CAHN
MOLINDONE HYDROCHLORIDE
>D> CONCENTRATE; ORAL
>D> MOBAN
>D> + ENDO PHARMS 20MG/ML N17938 001 Ma DISC
>A> @ 20MG/ML N17938 001 Ma DISC
>D> TABLET; ORAL
>D> MOBAN
>D> + ENDO PHARMS 100MG N17111 008 Ma DISC
>A> @ 100MG N17111 008 Ma DISC
MORPHINE SULFATE
>A> INJECTABLE, LIPOSOMAL; EPIDURAL
>A> DEPODUR
>A> SKYEPHARMA 10MG/ML N21671 001 May 18, 2004 Ma NEWA
>A> 15MG/1.5ML(10MG/ML) N21671 002 May 18, 2004 Ma NEWA
>A> + 20MG/2ML(10MG/ML) N21671 003 May 18, 2004 Ma NEWA
INJECTABLE; INJECTION
MORPHINE SULFATE
>D> AP ABBOTT 0.5MG/ML N73509 001 Sep 30, 1992 Ma CAHN
>D> AP 0.5MG/ML N71849 001 May 11, 1988 Ma CAHN
>D> AP + 0.5MG/ML N19917 001 Oct 30, 1992 Ma CAHN
>D> AP 1MG/ML N73510 001 Sep 30, 1992 Ma CAHN
>D> AP 1MG/ML N71850 001 May 11, 1988 Ma CAHN
>D> AP + 1MG/ML N19916 001 Oct 30, 1992 Ma CAHN
>A> AP HOSPIRA 0.5MG/ML N73509 001 Sep 30, 1992 Ma CAHN
>A> AP 0.5MG/ML N71849 001 May 11, 1988 Ma CAHN
>A> AP + 0.5MG/ML N19917 001 Oct 30, 1992 Ma CAHN
>A> AP 1MG/ML N73510 001 Sep 30, 1992 Ma CAHN
>A> AP 1MG/ML N71850 001 May 11, 1988 Ma CAHN
>A> AP + 1MG/ML N19916 001 Oct 30, 1992 Ma CAHN
TABLET, EXTENDED RELEASE; ORAL
MORPHINE SULFATE
>A> AB KV PHARM 15MG N76733 001 May 19, 2004 Ma NEWA
>A> AB 60MG N76720 001 May 19, 2004 Ma NEWA
NALBUPHINE HYDROCHLORIDE
INJECTABLE; INJECTION
NALBUPHINE HCL
>D> AP ABBOTT 10MG/ML N70915 001 Feb 03, 1989 Ma CAHN
>D> AP 10MG/ML N70914 001 Feb 03, 1989 Ma CAHN
>D> AP 20MG/ML N70918 001 Feb 03, 1989 Ma CAHN
>D> AP 20MG/ML N70916 001 Feb 03, 1989 Ma CAHN
>A> AP HOSPIRA 10MG/ML N70915 001 Feb 03, 1989 Ma CAHN
>A> AP 10MG/ML N70914 001 Feb 03, 1989 Ma CAHN
>A> AP HOSPIRA 20MG/ML N70918 001 Feb 03, 1989 Ma CAHN
>A> AP 20MG/ML N70916 001 Feb 03, 1989 Ma CAHN
NALOXONE HYDROCHLORIDE
INJECTABLE; INJECTION
NALOXONE HCL
>D> AP ABBOTT 0.02MG/ML N70253 001 Jan 16, 1987 Ma CAHN
>D> AP 0.02MG/ML N70252 001 Jan 16, 1987 Ma CAHN
>D> AP 0.02MG/ML N70171 001 Sep 24, 1986 Ma CAHN
>D> AP 0.4MG/ML N70257 001 Jan 07, 1987 Ma CAHN
>D> AP 0.4MG/ML N70256 001 Jan 07, 1987 Ma CAHN
>D> AP 0.4MG/ML N70255 001 Jan 07, 1987 Ma CAHN
>D> AP 0.4MG/ML N70254 001 Jan 07, 1987 Ma CAHN
>D> @ 0.4MG/ML N70172 001 Sep 24, 1986 Ma CAHN
>A> AP HOSPIRA 0.02MG/ML N70253 001 Jan 16, 1987 Ma CAHN
>A> AP 0.02MG/ML N70252 001 Jan 16, 1987 Ma CAHN
>A> AP 0.02MG/ML N70171 001 Sep 24, 1986 Ma CAHN
>A> AP 0.4MG/ML N70257 001 Jan 07, 1987 Ma CAHN
>A> AP 0.4MG/ML N70256 001 Jan 07, 1987 Ma CAHN
>A> AP 0.4MG/ML N70255 001 Jan 07, 1987 Ma CAHN
>A> AP 0.4MG/ML N70254 001 Jan 07, 1987 Ma CAHN
>A> @ 0.4MG/ML N70172 001 Sep 24, 1986 Ma CAHN
NITROGLYCERIN
INJECTABLE; INJECTION
NITROGLYCERIN
>D> AP + ABBOTT 5MG/ML N18531 001 Ma CAHN
>A> AP + HOSPIRA 5MG/ML N18531 001 Ma CAHN
NITROGLYCERIN IN DEXTROSE 5%
>D> AP ABBOTT 0.1MG/ML N74083 001 Oct 26, 1994 Ma CAHN
>D> AP 10MG/100ML N71846 001 Aug 31, 1990 Ma CAHN
>D> AP 20MG/100ML N71847 001 Aug 31, 1990 Ma CAHN
>D> AP 40MG/100ML N71848 001 Aug 31, 1990 Ma CAHN
>A> AP HOSPIRA 0.1MG/ML N74083 001 Oct 26, 1994 Ma CAHN
>A> AP 10MG/100ML N71846 001 Aug 31, 1990 Ma CAHN
>A> AP 20MG/100ML N71847 001 Aug 31, 1990 Ma CAHN
>A> AP 40MG/100ML N71848 001 Aug 31, 1990 Ma CAHN
NIZATIDINE
>A> SOLUTION; ORAL
>A> AXID
>A> + RELIANT PHARMS 15MG/ML N21494 001 May 25, 2004 Ma NEWA
NOREPINEPHRINE BITARTRATE
INJECTABLE; INJECTION
LEVOPHED
>D> AP + ABBOTT EQ 1MG BASE/ML N07513 001 Ma CAHN
>A> AP + HOSPIRA EQ 1MG BASE/ML N07513 001 Ma CAHN
OFLOXACIN
SOLUTION/DROPS; OPHTHALMIC
OCUFLOX
>D> + ALLERGAN 0.3% N19921 001 Jul 30, 1993 Ma CFTG
>A> AT + 0.3% N19921 001 Jul 30, 1993 Ma CFTG
>A> OFLOXACIN
>A> AT ALCON 0.3% N76231 001 May 14, 2004 Ma NEWA
>A> AT BAUSCH AND LOMB 0.3% N76622 001 May 14, 2004 Ma NEWA
>A> AT HI TECH PHARMA 0.3% N76615 001 May 14, 2004 Ma NEWA
>A> AT NOVEX 0.3% N76513 001 May 14, 2004 Ma NEWA
PANCURONIUM BROMIDE
INJECTABLE; INJECTION
PANCURONIUM BROMIDE
>D> AP ABBOTT 1MG/ML N72320 001 Jan 19, 1989 Ma CAHN
>D> AP 2MG/ML N72321 001 Jan 19, 1989 Ma CAHN
>A> AP HOSPIRA 1MG/ML N72320 001 Jan 19, 1989 Ma CAHN
>A> AP 2MG/ML N72321 001 Jan 19, 1989 Ma CAHN
PENTAMIDINE ISETHIONATE
INJECTABLE; INJECTION
PENTAMIDINE ISETHIONATE
>D> AP ABBOTT 300MG/VIAL N73479 001 Jun 30, 1992 Ma CAHN
>A> AP HOSPIRA 300MG/VIAL N73479 001 Jun 30, 1992 Ma CAHN
PENTAZOCINE LACTATE
INJECTABLE; INJECTION
TALWIN
>D> + ABBOTT EQ 30MG BASE/ML N16194 001 Ma CAHN
>A> + HOSPIRA EQ 30MG BASE/ML N16194 001 Ma CAHN
PENTOBARBITAL SODIUM
CAPSULE; ORAL
NEMBUTAL SODIUM
>D> + OVATION PHARMS 30MG N84095 001 Ma DISC
>A> @ 30MG N84095 001 Ma DISC
>D> AA + 100MG N83245 001 Ma DISC
>A> @ 100MG N83245 001 Ma DISC
SODIUM PENTOBARBITAL
>D> AA VALEANT PHARM INTL 100MG N83264 001 Ma CRLD
>A> + 100MG N83264 001 Ma CRLD
PHENYTOIN SODIUM
INJECTABLE; INJECTION
PHENYTOIN SODIUM
>D> @ ABBOTT 50MG/ML N89744 001 Dec 18, 1987 Ma CAHN
>D> @ 50MG/ML N89521 001 Mar 17, 1987 Ma CAHN
>A> @ HOSPIRA 50MG/ML N89744 001 Dec 18, 1987 Ma CAHN
>A> @ 50MG/ML N89521 001 Mar 17, 1987 Ma CAHN
PHYTONADIONE
INJECTABLE; INJECTION
VITAMIN K1
>D> BP ABBOTT 1MG/0.5ML N87954 001 Jul 25, 1983 Ma CAHN
>D> @ 10MG/ML N87956 001 Jul 25, 1983 Ma CAHN
>D> BP 10MG/ML N87955 001 Jul 25, 1983 Ma CAHN
>A> BP HOSPIRA 1MG/0.5ML N87954 001 Jul 25, 1983 Ma CAHN
>A> @ 10MG/ML N87956 001 Jul 25, 1983 Ma CAHN
>A> BP 10MG/ML N87955 001 Jul 25, 1983 Ma CAHN
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM
SOLUTION; ORAL
OCL
>D> + ABBOTT 6GM/100ML;75MG/100ML;168MG/100ML; N19284 001 Apr 30, 1986 Ma CAHN
146MG/100ML;1.29GM/100ML
>A> + HOSPIRA 6GM/100ML;75MG/100ML;168MG/100ML; N19284 001 Apr 30, 1986 Ma CAHN
146MG/100ML;1.29GM/100ML
POTASSIUM ACETATE
INJECTABLE; INJECTION
POTASSIUM ACETATE IN PLASTIC CONTAINER
>D> + ABBOTT 2MEQ/ML N18896 001 Jul 20, 1984 Ma CAHN
>A> + HOSPIRA 2MEQ/ML N18896 001 Jul 20, 1984 Ma CAHN
POTASSIUM CHLORIDE
INJECTABLE; INJECTION
POTASSIUM CHLORIDE
>D> @ ABBOTT 1MEQ/ML N83345 003 Ma CAHN
>D> @ 1MEQ/ML N80205 003 Ma CAHN
>D> + 1.5MEQ/ML N83345 001 Ma CAHN
>D> AP 2MEQ/ML N83345 002 Ma CAHN
>D> AP + 2MEQ/ML N80205 001 Ma CAHN
>D> @ 2.4MEQ/ML N80205 004 Ma CAHN
>D> @ 3.2MEQ/ML N80205 005 Ma CAHN
>A> @ HOSPIRA 1MEQ/ML N83345 003 Ma CAHN
>A> @ 1MEQ/ML N80205 003 Ma CAHN
>A> + 1.5MEQ/ML N83345 001 Ma CAHN
>A> AP 2MEQ/ML N83345 002 Ma CAHN
>A> AP + 2MEQ/ML N80205 001 Ma CAHN
>A> @ 2.4MEQ/ML N80205 004 Ma CAHN
>A> @ HOSPIRA 3.2MEQ/ML N80205 005 Ma CAHN
POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER
>D> @ ABBOTT 14.9MG/ML N20161 005 Nov 30, 1992 Ma CAHN
>D> @ 745MG/100ML N20161 001 Nov 30, 1992 Ma CAHN
>A> @ HOSPIRA 14.9MG/ML N20161 005 Nov 30, 1992 Ma CAHN
>A> @ 745MG/100ML N20161 001 Nov 30, 1992 Ma CAHN
POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER
>D> AP + ABBOTT 29.8MG/ML N20161 006 Aug 11, 1998 Ma CAHN
>D> @ 1.49GM/100ML N20161 002 Nov 30, 1992 Ma CAHN
>A> AP + HOSPIRA 29.8MG/ML N20161 006 Aug 11, 1998 Ma CAHN
>A> @ 1.49GM/100ML N20161 002 Nov 30, 1992 Ma CAHN
POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER
>D> AP + ABBOTT 2.24GM/100ML N20161 003 Aug 11, 1998 Ma CAHN
>A> AP + HOSPIRA 2.24GM/100ML N20161 003 Aug 11, 1998 Ma CAHN
POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER
>D> AP + ABBOTT 2.98GM/100ML N20161 004 Aug 11, 1998 Ma CAHN
>A> AP + HOSPIRA 2.98GM/100ML N20161 004 Aug 11, 1998 Ma CAHN
POTASSIUM CHLORIDE; SODIUM CHLORIDE
INJECTABLE; INJECTION
POTASSIUM CHLORIDE 20MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
>D> AP ABBOTT 149MG/100ML;900MG/100ML N19686 001 Oct 17, 1988 Ma CAHN
>A> AP HOSPIRA 149MG/100ML;900MG/100ML N19686 001 Oct 17, 1988 Ma CAHN
POTASSIUM CHLORIDE 40MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
>D> AP ABBOTT 298MG/100ML;900MG/100ML N19686 002 Oct 17, 1988 Ma CAHN
>A> AP HOSPIRA 298MG/100ML;900MG/100ML N19686 002 Oct 17, 1988 Ma CAHN
POTASSIUM CHLORIDE; SODIUM CHLORIDE; TROMETHAMINE
INJECTABLE; INJECTION
THAM-E
>D> @ ABBOTT 370MG/VIAL;1.75GM/VIAL;36GM/VIAL N13025 001 Ma CAHN
>A> @ HOSPIRA 370MG/VIAL;1.75GM/VIAL;36GM/VIAL N13025 001 Ma CAHN
PREDNISOLONE
TABLET; ORAL
PREDNISOLONE
>D> BX EVERYLIFE 2.5MG N84439 002 Ma DISC
>A> @ 2.5MG N84439 002 Ma DISC
>D> BX 5MG N84439 003 Ma DISC
>A> @ 5MG N84439 003 Ma DISC
>D> SPERTI 1MG N80358 001 Ma DISC
>A> @ 1MG N80358 001 Ma DISC
>D> BX 2.5MG N80358 002 Ma DISC
>A> @ 2.5MG N80358 002 Ma DISC
>D> BX 5MG N80358 003 Ma DISC
>A> @ 5MG N80358 003 Ma DISC
PREDNISOLONE SODIUM PHOSPHATE
SOLUTION; ORAL
PREDNISOLONE SODIUM PHOSPHATE
>A> AA PADDOCK EQ 5MG BASE/5ML N75988 001 May 25, 2004 Ma NEWA
PROCAINAMIDE HYDROCHLORIDE
INJECTABLE; INJECTION
PROCAINAMIDE HCL
>D> AP ABBOTT 100MG/ML N89069 001 Feb 12, 1986 Ma CAHN
>D> AP 500MG/ML N89537 001 Aug 25, 1987 Ma CAHN
>D> AP 500MG/ML N89070 001 Feb 12, 1986 Ma CAHN
>A> AP HOSPIRA 100MG/ML N89069 001 Feb 12, 1986 Ma CAHN
>A> AP 500MG/ML N89537 001 Aug 25, 1987 Ma CAHN
>A> AP 500MG/ML N89070 001 Feb 12, 1986 Ma CAHN
PROCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
NOVOCAIN
>D> AP + ABBOTT 1% N85362 003 Ma CAHN
>D> AP + 2% N85362 004 Ma CAHN
>D> + 10% N86797 001 Ma CAHN
>A> AP + HOSPIRA 1% N85362 003 Ma CAHN
>A> AP + 2% N85362 004 Ma CAHN
>A> + HOSPIRA 10% N86797 001 Ma CAHN
PROCAINE HCL
>D> AP ABBOTT 1% N80416 001 Ma CAHN
>D> AP 2% N80416 002 Ma CAHN
>A> AP HOSPIRA 1% N80416 001 Ma CAHN
>A> AP 2% N80416 002 Ma CAHN
PROCHLORPERAZINE EDISYLATE
INJECTABLE; INJECTION
PROCHLORPERAZINE EDISYLATE
>D> AP ABBOTT EQ 5MG BASE/ML N89703 001 Apr 07, 1988 Ma CAHN
>A> AP BEDFORD EQ 5MG BASE/ML N40540 001 May 28, 2004 Ma NEWA
>A> AP HOSPIRA EQ 5MG BASE/ML N89703 001 Apr 07, 1988 Ma CAHN
PROMETHAZINE HYDROCHLORIDE
INJECTABLE; INJECTION
PROMETHAZINE HCL
>D> AP ABBOTT 25MG/ML N40372 001 Jun 08, 2000 Ma CAHN
>D> AP 50MG/ML N83838 002 Ma CAHN
>D> AP 50MG/ML N40372 002 Jun 08, 2000 Ma CAHN
>A> AP HOSPIRA 25MG/ML N40372 001 Jun 08, 2000 Ma CAHN
>A> AP 50MG/ML N83838 002 Ma CAHN
>A> AP 50MG/ML N40372 002 Jun 08, 2000 Ma CAHN
SYRUP; ORAL
PROMETHAZINE HCL
>D> AA + HI TECH PHARMA 6.25MG/5ML N40026 001 Sep 25, 1998 Ma CRLD
>A> AA 6.25MG/5ML N40026 001 Sep 25, 1998 Ma CRLD
PROMETHAZINE PLAIN
>D> AA MORTON GROVE 6.25MG/5ML N87953 001 Nov 15, 1982 Ma CRLD
>A> AA + 6.25MG/5ML N87953 001 Nov 15, 1982 Ma CRLD
>A> RIFAXIMIN
>A> TABLET; ORAL
>A> XIFAXAN
>A> + SALIX PHARMS 200MG N21361 001 May 25, 2004 Ma NEWA
RITODRINE HYDROCHLORIDE
INJECTABLE; INJECTION
RITODRINE HCL
>D> + ABBOTT 10MG/ML N71618 001 Feb 28, 1991 Ma CAHN
>D> + 15MG/ML N71619 001 Feb 28, 1991 Ma CAHN
>A> + HOSPIRA 10MG/ML N71618 001 Feb 28, 1991 Ma CAHN
>A> + 15MG/ML N71619 001 Feb 28, 1991 Ma CAHN
RITODRINE HCL IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> + ABBOTT 30MG/100ML N71438 001 Jan 22, 1991 Ma CAHN
>A> + HOSPIRA 30MG/100ML N71438 001 Jan 22, 1991 Ma CAHN
ROPINIROLE HYDROCHLORIDE
TABLET; ORAL
REQUIP
>D> + GLAXOSMITHKLINE EQ 5MG BASE N20658 005 Sep 19, 1997 Ma CRLD
>A> EQ 5MG BASE N20658 005 Sep 19, 1997 Ma CRLD
SAFFLOWER OIL; SOYBEAN OIL
INJECTABLE; INJECTION
LIPOSYN II 10%
>D> + ABBOTT 5%;5% (5GM/100ML) N18997 001 Aug 27, 1984 Ma CAHN
>A> + HOSPIRA 5%;5% (5GM/100ML) N18997 001 Aug 27, 1984 Ma CAHN
LIPOSYN II 20%
>D> + ABBOTT 10%;10% (10GM/100ML) N18991 001 Aug 27, 1984 Ma CAHN
>A> + HOSPIRA 10%;10% (10GM/100ML) N18991 001 Aug 27, 1984 Ma CAHN
SODIUM ACETATE, ANHYDROUS
INJECTABLE; INJECTION
SODIUM ACETATE IN PLASTIC CONTAINER
>D> + ABBOTT 2MEQ/ML N18893 001 May 04, 1983 Ma CAHN
>A> + HOSPIRA 2MEQ/ML N18893 001 May 04, 1983 Ma CAHN
SODIUM CHLORIDE
INJECTABLE; INJECTION
BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
>D> AP + ABBOTT 9MG/ML N18800 001 Oct 29, 1982 Ma CAHN
>A> AP + HOSPIRA 9MG/ML N18800 001 Oct 29, 1982 Ma CAHN
SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
>D> AP ABBOTT 450MG/100ML N19759 001 Jun 08, 1988 Ma CAHN
>D> AP 450MG/100ML N18090 001 Ma CAHN
>A> AP HOSPIRA 450MG/100ML N19759 001 Jun 08, 1988 Ma CAHN
>A> AP 450MG/100ML N18090 001 Ma CAHN
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
>D> AP ABBOTT 9MG/ML N19465 002 Jul 15, 1985 Ma CAHN
>D> AP 9MG/ML N19217 001 Jul 13, 1984 Ma CAHN
>D> AP 9MG/ML N18803 001 Oct 29, 1982 Ma CAHN
>D> AP 900MG/100ML N19480 001 Sep 17, 1985 Ma CAHN
>D> AP 900MG/100ML N19465 001 Jul 15, 1985 Ma CAHN
>D> AP 900MG/100ML N16366 001 Ma CAHN
>A> AP HOSPIRA 9MG/ML N19465 002 Jul 15, 1985 Ma CAHN
>A> AP 9MG/ML N19217 001 Jul 13, 1984 Ma CAHN
>A> AP 9MG/ML N18803 001 Oct 29, 1982 Ma CAHN
>A> AP 900MG/100ML N19480 001 Sep 17, 1985 Ma CAHN
>A> AP 900MG/100ML N19465 001 Jul 15, 1985 Ma CAHN
>A> AP 900MG/100ML N16366 001 Ma CAHN
SODIUM CHLORIDE IN PLASTIC CONTAINER
>D> ABBOTT 2.5MEQ/ML N18897 001 Jul 20, 1984 Ma CAHN
>A> HOSPIRA 2.5MEQ/ML N18897 001 Jul 20, 1984 Ma CAHN
SOLUTION; IRRIGATION
SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
>D> @ ABBOTT 450MG/100ML N18380 001 Ma CAHN
>D> AT 450MG/100ML N17670 001 Ma CAHN
>A> @ HOSPIRA 450MG/100ML N18380 001 Ma CAHN
>A> AT 450MG/100ML N17670 001 Ma CAHN
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
>D> AT ABBOTT 900MG/100ML N18314 001 Ma CAHN
>D> AT 900MG/100ML N17514 001 Ma CAHN
>A> AT HOSPIRA 900MG/100ML N18314 001 Ma CAHN
>A> AT 900MG/100ML N17514 001 Ma CAHN
SODIUM LACTATE
INJECTABLE; INJECTION
SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER
>D> AP ABBOTT 1.87GM/100ML N18249 001 Ma CAHN
>A> AP HOSPIRA 1.87GM/100ML N18249 001 Ma CAHN
SODIUM LACTATE IN PLASTIC CONTAINER
>D> ABBOTT 5MEQ/ML N18947 001 Sep 05, 1984 Ma CAHN
>A> HOSPIRA 5MEQ/ML N18947 001 Sep 05, 1984 Ma CAHN
SODIUM NITROPRUSSIDE
INJECTABLE; INJECTION
NITROPRESS
>D> AP + ABBOTT 25MG/ML N71961 001 Aug 01, 1988 Ma CAHN
>D> + 50MG/VIAL N70566 001 Jun 09, 1986 Ma CAHN
>A> AP + HOSPIRA 25MG/ML N71961 001 Aug 01, 1988 Ma CAHN
>A> + 50MG/VIAL N70566 001 Jun 09, 1986 Ma CAHN
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
INJECTABLE; INJECTION
SODIUM PHOSPHATES IN PLASTIC CONTAINER
>D> ABBOTT 142MG/ML;276MG/ML N18892 001 May 10, 1983 Ma CAHN
>A> HOSPIRA 142MG/ML;276MG/ML N18892 001 May 10, 1983 Ma CAHN
SOMATROPIN RECOMBINANT
INJECTABLE; INJECTION
SAIZEN
>D> BX SERONO 6MG/VIAL N19764 001 Oct 08, 1996 Ma DISC
>A> @ 6MG/VIAL N19764 001 Oct 08, 1996 Ma DISC
ZORBTIVE
>D> BX SERONO INC 4MG/VIAL N21597 001 Dec 01, 2003 Ma DISC
>A> @ 4MG/VIAL N21597 001 Dec 01, 2003 Ma DISC
>D> BX 5MG/VIAL N21597 002 Dec 01, 2003 Ma DISC
>A> @ 5MG/VIAL N21597 002 Dec 01, 2003 Ma DISC
>D> BX 6MG/VIAL N21597 003 Dec 01, 2003 Ma DISC
>A> @ SERONO INC 6MG/VIAL N21597 003 Dec 01, 2003 Ma DISC
SOYBEAN OIL
INJECTABLE; INJECTION
LIPOSYN III 10%
>D> AP + ABBOTT 10% N18969 001 Sep 24, 1984 Ma CAHN
>A> AP + HOSPIRA 10% N18969 001 Sep 24, 1984 Ma CAHN
LIPOSYN III 20%
>D> AP + ABBOTT 20% N18970 001 Sep 25, 1984 Ma CAHN
>A> AP + HOSPIRA 20% N18970 001 Sep 25, 1984 Ma CAHN
LIPOSYN III 30%
>D> AP + ABBOTT 30% N20181 001 Jan 13, 1998 Ma CAHN
>A> AP + HOSPIRA 30% N20181 001 Jan 13, 1998 Ma CAHN
SUCCINYLCHOLINE CHLORIDE
INJECTABLE; INJECTION
QUELICIN
>D> AP + ABBOTT 20MG/ML N08845 006 Ma CAHN
>A> AP + HOSPIRA 20MG/ML N08845 006 Ma CAHN
QUELICIN PRESERVATIVE FREE
>D> AP + ABBOTT 20MG/ML N08845 001 Ma CAHN
>D> @ 50MG/ML N08845 002 Ma CAHN
>D> + 100MG/ML N08845 004 Ma CAHN
>A> AP + HOSPIRA 20MG/ML N08845 001 Ma CAHN
>A> @ 50MG/ML N08845 002 Ma CAHN
>A> + 100MG/ML N08845 004 Ma CAHN
SUFENTANIL CITRATE
INJECTABLE; INJECTION
SULFENTANIL CITRATE
>D> AP ABBOTT EQ 0.05MG BASE/ML N74534 001 Dec 11, 1996 Ma CAHN
>A> AP HOSPIRA EQ 0.05MG BASE/ML N74534 001 Dec 11, 1996 Ma CAHN
SULFAMETHOXAZOLE; TRIMETHOPRIM
INJECTABLE; INJECTION
SULFAMETHOXAZOLE AND TRIMETHOPRIM
>D> AP ABBOTT 80MG/ML;16MG/ML N73199 001 Sep 11, 1992 Ma CAHN
>A> AP HOSPIRA 80MG/ML;16MG/ML N73199 001 Sep 11, 1992 Ma CAHN
TECHNETIUM TC-99M MEDRONATE KIT
INJECTABLE; INJECTION
>A> DRAXIMAGE MDP
>A> AP + DRAXIMAGE N/A N18035 001 Ma CTNA
>D> TECHNESCAN MDP KIT
>D> AP + DRAXIMAGE N/A N18035 001 Ma CTNA
TERBUTALINE SULFATE
INJECTABLE; INJECTION
TERBUTALINE SULFATE
>A> AP AM PHARM 1MG/ML N76887 001 May 26, 2004 Ma NEWA
THEOPHYLLINE
INJECTABLE; INJECTION
THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> AP + ABBOTT 4MG/ML N19211 007 Dec 14, 1984 Ma CAHN
>D> AP + 40MG/100ML N19211 001 Dec 14, 1984 Ma CAHN
>D> AP + 80MG/100ML N19211 002 Dec 14, 1984 Ma CAHN
>D> AP + 160MG/100ML N19211 003 Dec 14, 1984 Ma CAHN
>D> AP + 200MG/100ML N19211 004 Dec 14, 1984 Ma CAHN
>D> AP + 320MG/100ML N19211 006 Jan 20, 1988 Ma CAHN
>D> AP + 400MG/100ML N19211 005 Dec 14, 1984 Ma CAHN
>A> AP + HOSPIRA 4MG/ML N19211 007 Dec 14, 1984 Ma CAHN
>A> AP + 40MG/100ML N19211 001 Dec 14, 1984 Ma CAHN
>A> AP + 80MG/100ML N19211 002 Dec 14, 1984 Ma CAHN
>A> AP + 160MG/100ML N19211 003 Dec 14, 1984 Ma CAHN
>A> AP + 200MG/100ML N19211 004 Dec 14, 1984 Ma CAHN
>A> AP + 320MG/100ML N19211 006 Jan 20, 1988 Ma CAHN
>A> AP + 400MG/100ML N19211 005 Dec 14, 1984 Ma CAHN
THIAMINE HYDROCHLORIDE
INJECTABLE; INJECTION
THIAMINE HCL
>D> AP ABBOTT 100MG/ML N40079 001 May 03, 1996 Ma CAHN
>A> AP HOSPIRA 100MG/ML N40079 001 May 03, 1996 Ma CAHN
>A> TINIDAZOLE
>A> TABLET; ORAL
>A> TINDAMAX
>A> PRESUTTI LABS 250MG N21618 001 May 17, 2004 Ma NEWA
>A> + 500MG N21618 002 May 17, 2004 Ma NEWA
TOBRAMYCIN SULFATE
INJECTABLE; INJECTION
TOBRAMYCIN SULFATE
>D> AP ABBOTT EQ 10MG BASE/ML N63112 001 Apr 30, 1991 Ma CAHN
>D> AP EQ 10MG BASE/ML N63080 001 Apr 30, 1991 Ma CAHN
>D> AP EQ 40MG BASE/ML N63161 001 May 29, 1991 Ma CAHN
>D> AP + EQ 40MG BASE/ML N63116 001 May 18, 1992 Ma CAHN
>D> AP EQ 40MG BASE/ML N63111 001 Apr 30, 1991 Ma CAHN
>A> AP HOSPIRA EQ 10MG BASE/ML N63112 001 Apr 30, 1991 Ma CAHN
>A> AP EQ 10MG BASE/ML N63080 001 Apr 30, 1991 Ma CAHN
>A> AP EQ 40MG BASE/ML N63161 001 May 29, 1991 Ma CAHN
>A> AP + EQ 40MG BASE/ML N63116 001 May 18, 1992 Ma CAHN
>A> AP EQ 40MG BASE/ML N63111 001 Apr 30, 1991 Ma CAHN
TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
>D> + ABBOTT EQ 1.2MG BASE/ML N63081 003 Jul 31, 1990 Ma CAHN
>D> + EQ 1.6MG BASE/ML N63081 006 Jun 02, 1993 Ma CAHN
>D> + EQ 80MG BASE/100ML N63081 001 Jul 31, 1990 Ma CAHN
>A> + HOSPIRA EQ 1.2MG BASE/ML N63081 003 Jul 31, 1990 Ma CAHN
>A> + EQ 1.6MG BASE/ML N63081 006 Jun 02, 1993 Ma CAHN
>A> + EQ 80MG BASE/100ML N63081 001 Jul 31, 1990 Ma CAHN
TRAVOPROST
SOLUTION/DROPS; OPHTHALMIC
TRAVATAN
>A> + ALCON 0.004% N21257 001 Mar 16, 2001 Ma CAHN
>D> + ALCON UNIVERSAL 0.004% N21257 001 Mar 16, 2001 Ma CAHN
TRIMETHOBENZAMIDE HYDROCHLORIDE
INJECTABLE; INJECTION
TRIMETHOBENZAMIDE HCL
>D> AP ABBOTT 100MG/ML N88804 001 Apr 03, 1987 Ma CAHN
>A> AP HOSPIRA 100MG/ML N88804 001 Apr 03, 1987 Ma CAHN
>D> TROLAMINE POLYPEPTIDE OLEATE CONDENSATE
>D> SOLUTION/DROPS; OTIC
>D> CERUMENEX
>D> + PURDUE FREDERICK 10% N11340 002 Ma DISC
>A> @ 10% N11340 002 Ma DISC
TROMETHAMINE
INJECTABLE; INJECTION
THAM
>D> + ABBOTT 3.6GM/100ML N13025 002 Ma CAHN
>A> + HOSPIRA 3.6GM/100ML N13025 002 Ma CAHN
>A> TROSPIUM CHLORIDE
>A> TABLET; ORAL
>A> SANCTURA
>A> + INDEVUS 20MG N21595 001 May 28, 2004 Ma NEWA
TUBOCURARINE CHLORIDE
INJECTABLE; INJECTION
TUBOCURARINE CHLORIDE
>D> AP + ABBOTT 3MG/ML N06095 001 Ma CAHN
>A> AP + HOSPIRA 3MG/ML N06095 001 Ma CAHN
UREA
INJECTABLE; INJECTION
STERILE UREA
>D> @ ABBOTT 40GM/VIAL N17698 001 Ma CAHN
>A> @ HOSPIRA 40GM/VIAL N17698 001 Ma CAHN
UREAPHIL
>D> + ABBOTT 40GM/VIAL N12154 001 Ma CAHN
>A> + HOSPIRA 40GM/VIAL N12154 001 Ma CAHN
VANCOMYCIN HYDROCHLORIDE
INJECTABLE; INJECTION
VANCOMYCIN HCL
>D> AP ABBOTT EQ 500MG BASE/VIAL N62931 001 Oct 29, 1992 Ma CAHN
>D> AP EQ 500MG BASE/VIAL N62911 001 Aug 04, 1988 Ma CAHN
>D> AP EQ 1GM BASE/VIAL N62933 001 Oct 29, 1992 Ma CAHN
>D> AP EQ 1GM BASE/VIAL N62912 001 Aug 04, 1988 Ma CAHN
>D> AP EQ 5GM BASE/VIAL N63076 001 Dec 21, 1990 Ma CAHN
>A> AP HOSPIRA EQ 500MG BASE/VIAL N62931 001 Oct 29, 1992 Ma CAHN
>A> AP EQ 500MG BASE/VIAL N62911 001 Aug 04, 1988 Ma CAHN
>A> AP EQ 1GM BASE/VIAL N62933 001 Oct 29, 1992 Ma CAHN
>A> AP EQ 1GM BASE/VIAL N62912 001 Aug 04, 1988 Ma CAHN
>A> AP EQ 5GM BASE/VIAL N63076 001 Dec 21, 1990 Ma CAHN
VECURONIUM BROMIDE
INJECTABLE; INJECTION
VECURONIUM BROMIDE
>D> + ABBOTT 4MG/VIAL N75558 001 Sep 11, 2001 Ma CAHN
>D> AP 10MG/VIAL N75164 001 Oct 21, 1999 Ma CAHN
>D> AP 20MG/VIAL N75164 002 Oct 21, 1999 Ma CAHN
>A> + HOSPIRA 4MG/VIAL N75558 001 Sep 11, 2001 Ma CAHN
>A> AP 10MG/VIAL N75164 001 Oct 21, 1999 Ma CAHN
>A> AP 20MG/VIAL N75164 002 Oct 21, 1999 Ma CAHN
VENLAFAXINE HYDROCHLORIDE
TABLET; ORAL
EFFEXOR
>D> + WYETH PHARMS INC EQ 50MG BASE N20151 003 Dec 28, 1993 Ma CRLD
>A> EQ 50MG BASE N20151 003 Dec 28, 1993 Ma CRLD
>D> EQ 100MG BASE N20151 005 Dec 28, 1993 Ma CRLD
>A> + EQ 100MG BASE N20151 005 Dec 28, 1993 Ma CRLD
VERAPAMIL HYDROCHLORIDE
INJECTABLE; INJECTION
VERAPAMIL HCL
>D> AP ABBOTT 2.5MG/ML N75136 001 Oct 20, 1998 Ma CAHN
>D> AP 2.5MG/ML N70740 001 May 06, 1987 Ma CAHN
>D> AP 2.5MG/ML N70739 001 May 06, 1987 Ma CAHN
>D> AP 2.5MG/ML N70738 001 May 06, 1987 Ma CAHN
>D> AP 2.5MG/ML N70737 001 May 06, 1987 Ma CAHN
>D> AP 2.5MG/ML N70577 001 Feb 02, 1987 Ma CAHN
>A> AP HOSPIRA 2.5MG/ML N75136 001 Oct 20, 1998 Ma CAHN
>A> AP 2.5MG/ML N70740 001 May 06, 1987 Ma CAHN
>A> AP 2.5MG/ML N70739 001 May 06, 1987 Ma CAHN
>A> AP 2.5MG/ML N70738 001 May 06, 1987 Ma CAHN
>A> AP 2.5MG/ML N70737 001 May 06, 1987 Ma CAHN
>A> AP 2.5MG/ML N70577 001 Feb 02, 1987 Ma CAHN
TABLET, EXTENDED RELEASE; ORAL
VERAPAMIL HCL
>D> @ BARR 120MG N75072 001 May 25, 1999 Ma CMFD
>A> AB 120MG N75072 001 May 25, 1999 Ma CMFD
>D> @ 240MG N75072 003 May 25, 1999 Ma CMFD
>A> AB 240MG N75072 003 May 25, 1999 Ma CMFD
WATER FOR INJECTION, STERILE
LIQUID; N/A
BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER
>D> AP ABBOTT 100% N18802 001 Oct 27, 1982 Ma CAHN
>A> AP HOSPIRA 100% N18802 001 Oct 27, 1982 Ma CAHN
STERILE WATER FOR INJECTION IN PLASTIC CONTAINER
>D> AP ABBOTT 100% N19869 001 Dec 26, 1989 Ma CAHN
>D> AP 100% N18801 001 Oct 27, 1982 Ma CAHN
>D> AP 100% N18233 001 Ma CAHN
>D> AP B BRAUN 100% N19077 001 Mar 02, 1984 Ma DISC
>A> @ 100% N19077 001 Mar 02, 1984 Ma DISC
>A> AP HOSPIRA 100% N19869 001 Dec 26, 1989 Ma CAHN
>A> AP 100% N18801 001 Oct 27, 1982 Ma CAHN
>A> AP 100% N18233 001 Ma CAHN
WATER FOR IRRIGATION, STERILE
LIQUID; IRRIGATION
STERILE WATER IN PLASTIC CONTAINER
>D> AT ABBOTT 100% N18313 001 Ma CAHN
>D> AT 100% N17513 001 Ma CAHN
>A> AT HOSPIRA 100% N18313 001 Ma CAHN
>A> AT 100% N17513 001 Ma CAHN
ZINC CHLORIDE
INJECTABLE; INJECTION
ZINC CHLORIDE IN PLASTIC CONTAINER
>D> + ABBOTT EQ 1MG ZINC/ML N18959 001 Jun 26, 1986 Ma CAHN
>A> + HOSPIRA EQ 1MG ZINC/ML N18959 001 Jun 26, 1986 Ma CAHN
none.
 Back
to Top 
Index Page
Date Created: June 22, 2004 |
|
